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ABSTRACT 
 
   A total of 100 actinomycetes isolated  from soils from four provinces 
in southern Thailand were screened for their ability to produce antimicrobial  
substances by cross streak and  hyphal growth inhibition tests  against ten human 
pathogens: Staphylococcus aureus ATCC 25923, methicillin-resistant  Staphylococcus 
aureus SK1, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, 
Cryptococcus neoformans  ATCC 90112 and ATCC 90113, Candida  albicans ATCC 
90028 and  NCPF 3153, Microsporum gypseum  and Penicillium  marneffei clinical 
isolates. Eighty percents of the isolates showed antimicrobial activity against at least 
one test microorganism. Among them, 8% exhibited selective antibacterial activity, 
32% had only antifungal activity and 40% displayed both antibacterial and antifungal 
activities. For antibacterial activity, 40% of soil actinomycetes inhibited both strains 
of S. aureus and only 9 and 15% inhibited E. coli and P. aeruginosa, respectively. For 
antifungal activity, 49, 41, 30 and 21% inhibited C. neoformans, P. marneffei,           
C. albicans and M. gypseum, respectively. Forty-six active isolates that showed 
inhibition zone over 25 mm and hyphal growth inhibition over 80% were selected and 
cultured in Yeast Malt Extract (YME) broth for extraction of bioactive compound. 
Crude extracts were then tested for their minimal inhibitory concentrations (MICs),
 
minimal bactericidal concentrations
 
(MBCs) and minimal fungicidal concentrations 
(MFCs) by colorimetric broth microdilution methods. Ninety extracts out of 138 
extracts (65%) from 46 actinomycete isolates (100%) were inhibitory with 
MIC/MBC-MFC in the range of 0.5-200/2->200 µg/ml. The extracts were more 
effective against bacteria than fungi. Crude hexane extract from the cells of ACK21 
 viii 
(ACK21CH) exhibited the strongest antibacterial activity against S. aureus and MRSA 
with MIC/MBC 0.5/4 and 0.5/8 µg/ml, respectively followed by crude ethyl acetate 
extract from the cells of ACK20 (ACK20CE) against S. aureus and MRSA with 
MIC/MBC 2/8 and 0.5/2 µg/ml, respectively. In addition, ACK21CH also showed the 
strongest activity against C. albicans NCPF 3153 (MIC/MFC 4/128 µg/ml). 
Furthermore scanning electron microscopic study showed that ACK21CH and 
ACK20CE strongly destroyed S. aureus cells causing cytoplasm leakage and cell 
death. The effects of agitation, temperature and initial pH of culture medium on the 
production of antimicrobial metabolites by the isolates ACK21 and ACK20 were 
investigated. The optimum condition for ACK21 was observed at the static condition, 
pH7 and temperature 30oC and ACK20 at the static condition, pH6 and 7 and 
temperature 25oC Assayed against both strains of S. aureus. Based on morphological 
characteristics and 16S rDNA analysis, ACK21 was identified as Streptomyces sp. and 
ACK20 as Amycolatopsis echigonensis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
ACKNOWLEDGEMENTS 
 
I would like to express my deepest appreciation to my advisor, Assoc. 
Prof. Dr. Souwalak Phongpaichit for her scientific guidance, kindly providing me with 
the opportunity to pursue Bachelor and Master degree at Prince of Songkla University 
and also for her continuous support.  
I am grateful to my co-advisor Dr. Ampaithip Sukhoom, the 
Department of Microbiology, Faculty of Sciences, Prince of Songkla University for 
her advice and Prof. Dr. Vatcharin Rukachaisirikul, Department of Chemistry, Faculty 
of Science, Prince of Songkla University, Thailand for actinomycetes extraction. 
Special thank are all members of Organic Chemistry Laboratory (CH402), Department 
of Chemistry, Faculty of Science, Prince of Songkla University for their friendships 
and helps. I would like to express a special acknowledgement to Mr. Sawai Boukaew, 
Department of Pest Management, Faculty of Natural Resources, Prince of Songkla 
University for kindly providing some of actinomycetes for this study. 
This research was made possible by a scholarship from Center of 
Excellence for Innovation in Chemistry (PERCH-CIC) and the Graduate School and 
Natural Product Research Center, Prince of Songkla University for partial financial 
support. 
I would also like to thank the members of Mycology Laboratory 
(PR504), Prince of Songkla University for their support over the year. I am very 
grateful to P' Mook, P' Sing, P' Som, P' Pla, P' Ann, P' Joy, Far, Poo, N' Tum and N' 
Pang for their friendships and assistance in the laboratory experiment and I also thank 
all my teachers in the Department of Microbiology, Prince of Songkla University for 
their generosity while teaching me. 
 
Finally, I would like to express my deepest appreciation to my family 
and Police Lieutenant. Jerapong Jeadkong for their loves and financial support. 
 
Sunanta Sawasdee 
 
 x 
THE RELEVANCE OF THE RESEARCH WORK TO THAILAND 
 
 
Clinically-important bacteria, such as Staphylococcus aureus, are 
becoming resistant to commonly used antibiotics. Nowadays, new resistant strains 
emerge more quickly while the rate of discovery of new antibiotics is slowing down. 
Because of this, many scientists have focused on screening programs of 
microorganisms, primarily of actinomycetes, for their potential to produce new 
antibiotics against resistant strains. Many of actinomycetes are known to have the 
capacity to synthesize bioactive secondary metabolites, especially antibiotics. Almost 
80% of the world´s antibiotics are known to come from actinomycetes, mostly from 
the genera Streptomyces and Micromonospora. Over 50 different antibiotics have been 
isolated from Streptomyces sp. The purpose of this research aimed to isolate 
actinomycetes from soils and test for their ability to produce antimicrobial substances 
against human pathogens. In this study, crude hexane extract from the cells of ACK21 
(ACK21CH) exhibited the strongest antibacterial activity against S. aureus and 
methicillin-resistant S. aureus (MRSA) with MIC/MBC 0.5/4 and 0.5/8 µg/ml, 
respectively followed by the ethyl acetate extract from the cells of ACK20 
(ACK20CE) against S. aureus and MRSA with MIC/MBC 2/8 µg/ml, 0.5/2 µg/ml, 
respectively which were comparable to vancomycin (MIC 0.5-1 µg/ml). In addition, 
scanning electron microscopic study showed that ACK21CH and ACK20CE strongly 
destroyed S. aureus cells causing cytoplasm leakage and cell death. The culture 
conditions of both strains on the production of antimicrobial metabolites were also 
investigated. These two strains are a good source of antibacterial agents. They were 
identified based on morphological characteristics and the analysis of 16S rDNA to be 
Amycolatopsis echigonensis ACK20 and Streptomyces sp. ACK21. The isolation of 
active compounds and their structural elucidation are under investigation by the 
chemists. The mechanisms of action of bioactive compounds from ACK21 and 
ACK20 will be investigated.  
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 CHAPTER 1 
 
INTRODUCTION 
 
 
 
 
1.1 Background and rationale 
 
  Infectious diseases caused by drug-resistant bacteria and fungi are a 
major worldwide problem (Alanis, 2005). There is a need to find new antimicrobial 
agents to combat them. Actinomycetes are an important source of bioactive substances 
that are important for both medical and economic values, particularly in biotechnology 
(Mitchell et al., 2004). About two-thirds of antibiotics are from actinomycetes 
(Takizawa et al., 1993), most of which were produced by various Streptomyces 
species. This group of bacteria is interesting because it has complex life cycle and its 
members are antibiotic producers with a number of species (Kelemen and Buttner, 
1999; Chater, 2001; Bentley et al., 2002; Willey et al., 2006; Nguyen et al., 2007). 
Many commercially available antibiotics are produced by Streptomyces spp. such as 
the antibacterial agents chloramphenicol, clindamycin, erythromycin, imipenem, 
streptomycin, tetracycline as well as antifungal agents amphotericin B and nystatin 
(Todar, 2012). Other bioactive compounds include anti-cancer compounds such as 
echinosporin (Morimoto and Imai, 1985) and limocrocin, an immunosuppressive 
agent, rapamycin, an insecticide macrolide compound (avermectin), and herbicides 
(phosphinothricin) are also produced by Streptomyces spp. (Goodfellow et al., 1988). 
Ruan (1994) reported that about 1,000 of the rare species of actinomycetes including 
Micromonospora 400 species, Nocardia 270 species, Actinomadura 170 species, 
Actinoplanes 150 species, Saccharopolyspora 50 species and Streptosporangium 40 
species produced antibiotics. The commercial production of antibiotics from rare 
actinomycetes such as the rifamycins produced by Amycolatopsis mediterranei, 
erythromycin produced by Saccharopolyspora erythraea, teicoplanin produced by 
Actinoplanes teichomymyceticus, and gentamicin and vancomycin from Amycolatopsis 
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orientalis and Micromonospora purpurea, respectively have also been reported 
(Lazzarini et al., 2000). However, in the last 20 years, the rates of discovery of new 
antibiotics from various sources have declined while the demand for antibiotics for the 
treatment of drug resistant pathogens and opportunistic diseases in AIDS patients and 
patients with organ transplantation is increasing all the time. Thus, seeking sources of 
new types of antibiotics is important and necessary (Schumacher et al., 2003) and 
actinomycetes are still probably the most interesting source. Screening programmes 
for antimicrobial agents from actinomycetes are still fairly common and one new 
biologically active agent (resistoflavine) has recently been isolated from Streptomyces 
chibaensis AUBN1/7. This compound showed a potent cytotoxic activity against cell 
lines viz. HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) (Gorajana 
et al., 2007) and showed both antibacterial and antifungal activity (Arasu et al., 2008, 
Yadav et al., 2009, Duraipandiyan et al., 2010, Aouiche et al., 2012, Dasari  et al., 
2012 ) 
 
 
1.2 Review of the literature  
1.2.1 The importance of antibiotics 
 
Antibiotics are substances normally of low molecular weight capable of 
inhibiting or slowing the growth of pathogenic microorganisms. They are often 
secondary metabolite produced by microorganisms and seem to have no definite role 
in the growth of the cell source. Microorganisms produce antibiotics normally during 
their late log phase of growth until their stationary phase. One of their key benefits to 
the source organism is said to be their ability to inhibit the growth of other 
microorganisms growing in the same environment in nature hence providing the 
source with a competitive advantage. Antibiotic producing microorganisms can then 
compete with others and survive in nature for a long time (Onlamoon, 2008) 
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1.2.2 The source of bioactive compound. 
1.2.2.1 Bioactive compound from chemical synthesis 
 
Antimicrobial compounds obtained from chemical synthesis are fewer 
in number than antibiotics from biological sources. Perhaps the best examples of 
antimicrobial agent from chemical synthesis are the sulfonamides (Figure 1a), the first 
antimicrobial agent synthesized in 1930. In 1962 nalidixic acid, a quinolone 
antimicrobial drug derived from chloroquine was discovered. After that many 
analogues have been synthesized and fluoroquinolone derivatives such as 
ciprofloxacin (Figure 1b) have been successfully developed.  In 1979, a synthetic 
substance oxazolidinone was synthesized and linezolid (Figure 1c) was the first 
commercially available 1,3-oxazolidinone antibiotic  (Blunt et al., 2005). It is very 
effective against Gram-positive bacteria including drug resistant strains such as 
methicillin-resistant Staphylococcus aureus (MRSA). 
 
 
 
 
 
 
 
 
Figure 1 Chemical structures of sulfamethoxazole (a), ciprofloxacin (b),  
    and linezolid (c). 
Source: Blunt et al. (2005) 
 
1.2.2.2 Bioactive compound from natural sources 
 
Natural sources of biologically important compounds are plants, 
animals and microorganisms. The use of plant bioactive compounds as therapeutic 
drugs has developed over a long time from such chemicals as aspirin, morphine and 
quinine (Figure 2), etc. Natural products derived from animals such as clarhamnoside 
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produced by Agelas clathorodes (sponge), carijenone produced by Carijoa multiflora 
(coral), and violatinctamine produced by Cystodytes violatinctus (sea squirt). Recently, 
many studies have focused on natural products from marine organisms including 
microorganisms for the active ingredients of new developments in anticancer drugs. In 
2009, approximately 1000 new compounds with biological activities were isolated 
(Blunt et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2  Chemical structures of aspirin (a), morphine (b), quinine (c), clarhamnoside              
(d), carijenone (e) and violatinctamine (f) 
Source: Blunt et al. (2005) 
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1.2.2.2.1 Antimicrobial substances produced by fungi  
 
Fungi are a good source of antibitoics. Antibiotics produced by fungi 
are such as penicillin, the first antibiotic produced by Penicillium notatum that can 
inhibit the growth of a wide range of bacteria, cephalosporin produced by 
Cephalosporium spp., fusidic acid produced by Fusidium coccineum and cyclosporine 
A produced by Trichoderma polysporum, etc (Onlamoon, 2008). 
 
1.2.2.2.2 Antimicrobial substances produced by bacteria. 
1.2.2.2.2.1 Gram-negative bacteria. 
 
                       Gram-negative bacteria including a number of Pseudomonas spp. 
produce antibiotics such as mupiracin, pirrolnitrin and sulfazecin while Myxobacteria 
can produce althiomycin, pyrrolnitrin, ambruticin, sorangicin A and B, etc (Onlamoon, 
2008). 
 
1.2.2.2.2.2 Gram-positive bacteria 
 
The Gram-positive bacteria that can produce antibiotics include the 
majority of Bacillus such as B. licheniformis (bacitracin), B. polymyxa (polymyxin) 
etc. However, the Gram-positive bacteria group of actinomycetes is the most 
important one for the production of antibiotics. It has been reported that approximately 
75 % of antibiotics are derived from actinomycetes isolated from soil, such as 
Nocardia lactamdurans produce nocardicin, rifamycins, and ristocetin etc. Examples 
of antibiotics from Streptomycetes such as actinomycin D, echinomycin, sporaviridin 
Al, filipin, enterocin, maltophilin and pyridindolol etc., and antibiotics from 
Micromonospora found both on land and sea, such as the BU-4664L and 
lkarugamycin etc (Onlamoon, 2008). 
A number of bioactive natural products produced by microorganisms 
are shown in Table 1. 
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Table 1 Approximate number of bioactive microbial natural products (2002)  
according to their producers 
 
 
Source 
 
Antibiotic 
 
Other 
bioactive 
metabolites 
 
Total 
bioactive 
metabolites 
 
Practically used 
(in human 
therapy) 
 
Inactive 
metabolites 
      
Bacteria 2900 900 3800 10-12 (8-10) 3000 - 5000 
Actinomycetales 8700 1400 10100 100-120 (70~75) 5000 - 10000 
Fungi 4900 3700 8600 30-35 (13-15) 2000 - 15000 
 
 
Total 
 
16500 
 
6000 
 
22500 
 
140-160 (~100) 
 
20000 - 25000 
 
Source: Berdy (2005)  
 
Actinomycetes are the most widely distributed groups of 
microorganism in nature. They are a large part of the microbial population of the soil 
(Oskay et al., 2004). Among actinomycetes, Streptomyces is the dominant genus. 
About 90% of the actinomycetes isolated from soil can be assigned to the genus 
Streptomyces (Paul and Clark, 1989).  
Obviously various actinomycetales, in particular the Streptomyces 
species and filamentous fungi, and to a lesser extent several bacterial species are the 
most noteworthy producers both in respect of numbers, versatility and diversity of 
structures of the produced metabolites. The significance and frequency of these main 
types of microoganisms as producers of bioactive metabolites had varied significantly 
during the last decades. In the beginning of the antibiotic era, antibiotics from fungal 
sources (penicillin, griseofulvin) and bacteria (gramicidin) were in the foreground of 
interest, but after the discovery of streptomycin and later chloramphenicol, 
tetracyclines and macrolides the attention turned to the Streptomyces species. In the 
fifties and sixties the majority (70%) of antibiotics were discovered from these 
species. In the next two decades the significance of the non-Streptomyces 
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actinomycetales species (rare actinos) increased, producing up to a 25-30% share of all 
known antibiotics (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Distribution of the discovered antibiotics according to their origin. 
Source: Berdy (2005) 
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From the early nineties the number of bioactive compounds isolated 
from various filamentous and other microorganisms and higher fungal species had 
continuously increased up to more than 50% by the turn of the millennium (2000). The 
interest in bacteria in recent years had only slightly increased. However, 45% of the 
presently known bioactive metabolites, from over 10,000 compounds were still 
isolated from various actinomycetales species, 34% from Streptomyces and 11% from 
the rare actinos. The most frequent producers, the Streptomyces species produce 7,600 
compounds (74% of all actinomycetales), while the rare actinos represent 26%, 
altogether 2,500 compounds. The representation of rare actinos products in 1970 was 
only 5%. In this group Micromonospora, Actinomadura, Streptoverticillium, 
Actinoplanes, Nocardia, Saccharopolyspora and Streptosporangium species were the 
most frequent producers, each produces several hundreds of antibiotics. The numbers 
of actinomycetales species, including the all rare actinos, known to produce bioactive 
metabolites, are summarized in Table 2. 
 
Table 2 Number of actinomycetales species producing bioactive microbial metabolites 
 
Actinomycetales No. of 
species 
Actinomycetales No. of 
species 
 
Streptomycetaceae: 
 
Thermomonosporaceae: 
    Streptomyces ~8000     Actinomadura 345 
    Streptoverticillium 258     Saccharothrix 68 
    Kitasatosporia 37     Microbispora 54 
    Chainia 30     Actinosynnema 51 
    Microellobosporia 11     Nocardiopsis 41 
    Nocardioides 9 
 
Micromonosporaceae: 
(Actinoplanetes) 
    Micromonospora 740 
    Actinoplanes 248 
    Dactylosporangium 58 
Microtetraspora/Nonomuria 
    Thermomonospora 
    Micropolyspora/Faenia 
    Thermoactinomyces 
    Thermopolyspora 
    Thermoactinopolyspora 
26/21 
19 
13/3 
14 
1 
1 
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Table 2 (Cont.) Number of actinomycetales species producing bioactive microbial 
metabolites 
 
Actinomycetales No. of 
species 
Actinomycetales No. of 
species 
Micromonosporaceae: 
(Actinoplanetes) 
 Mycobacteriaceae:  
(Actinobacteria) 
    Ampullariella 9 Nocardia 357 
    Glycomyces 2 Mycobacterium 57 
    Catenuloplanes 3 Arthrobacter 25 
    Catellatospora 1 Brevibacterium 17 
 
Pseudonocardiaceae: 
Proactinomyces 
Rhodococcus 
14 
13 
    Saccharopolyspora 131 Other (unclassified) species: 
 Amycalotopsis/Nocardia 120/357 Actinosporangium 30 
    Kibdellosporangium 34 Microellobosporia 11 
    Pseudonocardia 27 Frankia 7 
    Amycolata 12 Westerdykella 6 
    Saccharomonospora 2 Kitasatoa 5 
    Actinopolyspora 1 Synnenomyces 4 
 Sebekia 3 
Streptosporangiaceae: (Maduromycete) Elaktomyces  
Excelsospora 
3 
3 
    Streptosporangium 79      Waksmania 3 
    Streptoalloteichus 48      Alkalomyces 1 
    Spirillospora 11      Catellatospora 1 
    Planobispora 10      Erythrosporangium 1 
    Kutzneria 4      Streptoplanospora 1 
    Planomonospora 2      Microechinospora 1 
       Salinospora 1 
 
Source: Berdy (2005) 
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In the light of our accumulated knowledge and from statistical data, the 
potency of the Streptomyces species should not be underestimated. Their capacity to 
produce promising new compounds will certainly be unsurpassed for a long time and 
they still have been producing the majority of the antibiotics used in chemotherapy      
(Berdy, 2005). Many investigators are still looking for new bioactive compounds from 
Streptomyces spp. and have recently found that particular Streptomyces spp. can 
produce antibacterial activities against S. aureus, MRSA, vancomycin-resistant          
S. aureus (VRSA), B. subtilis, S. epidermidis, Enterococcus faecalis, Micrococcus 
luteus, E. coli, P. aeruginosa, Klebsiella sp. (Arasu et al., 2008; Selvameenal et al., 
2009; Yadav et al., 2009; Duraipandiyan et al., 2010; Aouiche et al., 2012; Dasari et 
al., 2012). 
 
 
1.2.2.2.3 Bioactive substances from actinomycetes 
1.2.2.2.3.1 Antimicrobial substances from actinomycetes 
 
Actinomycetes especially the genus Streptomyces are a good source of 
antibiotics (Table 3).  The most common antibiotics used to treat infections are from 
actinomycetes (45%), followed by fungi (38%) and other bacteria (17%). Although 
there are many commercially available antibiotics, there is a need to find new 
antimicrobial substances because of the problem of drug resistance. In Table 4 there 
are examples of studies for the screening of antibiotic producing actinomycetes and 
their antimicrobial compounds since the year 2000.  
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Table 3 Some antibiotics produced by Streptomyces spp. and their properties 
 
Antibiotic 
 
Source 
 
Spectrum Mode of action 
Amphotericin B 
 
S. nodosus 
 
Fungi 
Inactivate 
membranes 
containing sterol 
Chloramphenicol 
 
S. venezuelae 
 
Gram-positive and 
Gram-negative 
bacteria 
Inhibits protein 
synthesis 
(translation step) 
Chlortetracycline 
 
S. aureofaciens 
 
Gram-positive and 
Gram-negative 
bacteria and rickettsias 
Inhibits protein 
synthesis 
(translation step) 
Clindamycin S. lincolnensis 
Gram-positive and 
Gram-negative 
bacteria esp. anaerobic 
Bacteroides 
Inhibits protein 
synthesis 
(translation step) 
Erythromycin 
 
S. erythraeus 
 
Gram-positive 
bacteria, Gram-
negative bacteria not 
enterics, Neisseria, 
Legionella, 
Mycoplasma 
Inhibits protein 
synthesis 
(translation step) 
Imipenem S. cattleya 
Gram-positive and 
Gram-negative 
bacteria 
Inhibits steps in cell 
wall 
(peptidoglycan) 
synthesis and 
murein assembly 
Nystatin 
 
S. noursei 
 
Fungi (Candida) 
Inactivate 
membranes 
containing sterols 
Rifampicin S. mediterranei 
Gram-positive and 
Gram-negative 
bacteria, 
Mycobacterium 
tuberculosis 
Inhibits 
transcription 
(bacterial RNA 
polymerase) 
Streptomycin 
 
S. griseus 
 
Gram-positive and 
Gram-negative 
bacteria 
Inhibits protein 
synthesis 
(translation step) 
Tetracycline 
 
S. viridifaciens 
 
Gram-positive and 
Gram-negative 
bacteria, Rickettsias 
Inhibits protein 
synthesis 
(translation step) 
 
Source: Todar (2012) 
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Table 4 Bioactive substances from actinomycetes with antibacterial and antifungal 
activities 
 
Investigator Actinomycetes Substances produced/activity 
Capon et al., 
2000 
Actinomycetes 
species MST-
MA 190 
-  Lorneamides A and B, a new type of aromatic 
aminde compound belongs to tri-alkyl-
substituted benzenes.  
-  Lorneamides A can inhibit the growth of           
B. subtilis (LD99 50.0 µg/ml). 
Cho et al., 
2001 
Streptomyces sp. 
-  Lactone metabolites comprising 3 butanomides 
and 3-hydroxy-Y-butyrolactones.  
-  3-hydroxy-Y-butyrolactones (50.0 µg/disk) can 
inhibit the growth of C. albicans with an 
inhibition zone of 19.0 mm. 
Schumacher 
et al., 2001 
Nocardiopsis  
dassonvillei 
-  Kahakamides A and B 
-  Kahakamide A can inhibit B. subtilis. 
Woo et al., 
2002 
Streptomyces sp. 
strain AP77 
-  Heterologous protein consisting of 3 units of the 
SAP1, SAP2, and SAP3  
-  This protein could inhibit the growth of Pythium 
porphyrae the disease red rot in seaweed 
Porphyra spp. (MIC of 1.65 µg/disk) and   
Pythium ultimum (MIC of 6.3 µg/disk). 
Schumacher 
et al., 2003 
Streptomyces sp. 
strain BD21-2 
-  Bonactin from culture filtrate 
-  Bonactin can inhibit the growth of Bacillus  
megaterium, M. luteus, Klebsiella  pneumoniae, 
S. aureus, Alcaligenes faecalis, E. coli and 
Saccharomyces  cerevisiae with inhibition zones 
in the range 7-10 mm. 
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Table 4 (cont.) Bioactive substances from actinomycetes with antibacterial and 
antifungal activities 
 
Investigator Actinomycetes Substances produced/activity 
Stritzke et 
al., 2004 
Streptomyces sp. 
strain B6007 
- Two new caprolactones: (R)-10-methyl-6-
undecanolide and (6R, 10S)-10-methyl-6-
dodecanolide.  
- Caprolactones have the ability to inhibit the 
growth of Streptomyces viridochromogenes, S. 
aureus, Mucor miehei, and C. albicans. No 
activity against E. coli and B. subtilis. 
Sae-lim, 
2005 
 
Actinomycetes  
CNA053C 
isolated from sea 
in Thailand. 
-   Extract F5 can inhibit S. aureus, B. subtilis and 
E. faecalis with MIC values of 0.58, 0.29 and 
0.29 µg/ml, respectively. F5.2 extract inhibited 
S. aureus, B. subtilis, E. faecalis, P. aeruginosa, 
S. typhi and S. sonnei, with MIC values of 0.58, 
0.146, 0.29, 9.38, 150 and 300 µg/ml, 
respectively. 
Singh et al., 
2006 
Streptomyces 
spp. isolated 
from soil in India 
-   Broad spetrum Streptomyces spp. (12 isolates) 
inhibited B. subtilis, S. aureus, E. coli and 
Fusarium moniliforme.   
Parungao et 
al., 2007 
Micromonospora 
isolated form sea 
-   Actinomycetes 54 isolates inhibited E.coli, S. 
aureus, C. utilis and Aspergillus niger. 52% of 
actinomycetes had anti- E. coli, S. aureus, C. 
utilis and 13% had antifungal activity against  
A. niger.  
Arasu et al., 
2008 
Streptomyces 
spp. ERI-26 
-   ERI-26 showed activity against bacteria such as 
B. subtilis, S. aureus, S. epidermidis, E. faecalis 
and fungi such as C. albicans, A. niger and A. 
flavus. 
-  MIC of ERI-26 against S. epidermidis was 375 
µg/ml and against C. albicans  was 500 µg/ml  
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Table 4 (cont.) Bioactive substances from actinomycetes with antibacterial and 
antifungal activities 
 
Investigator Actinomycetes Substances produced/inhibition. 
Gandhimathi 
et al., 2008 
Streptomyces sp. 
 
-   Isolate CPI 13 produced anti- K. pneumonia 
with an inhibition zone of 65.94 mm and 
extract from CPI 13 inhibited C. tropicalis 
with MIC and MFC values of 10 and 12.5 
µg/ml, respectively. 
Sawasdee, 
2008 
 
Streptomyces spp. 
from soils from 
Thailand. 
 
-   Crude ethyl acetate extracts had antifungal 
activity against Cryptococcus neoformans with 
MIC values in the range of 2-128 and 1-32 
µg/ml, respectively and against S. aureus and 
MRSA with MIC values of 128 and 200 µg/ml.  
No extracts inhibited E. coli, P. aeruginosa 
and C. albicans. 
Manjula et 
al., 2009 
Actinomycetes 
isolated from soil 
-   Strain A2, A3, A5 inhibited Gram-positive and 
Gram-negative bacteria. The immobilized 
microorganisms were more effective than the 
free cell. 
Selvameenal 
et al., 2009 
Streptomyces  
hygroscopicus 
-   Production of anti-MRSA, VRSA, E. coli, P. 
aeruginosa, Klebsiella sp.  
Yadav et al., 
2009 
Streptomyces 
isolated from soil 
from Bay of 
Bengal, India 
- Strains A160, A161 and A164 inhibited 
growth of the Gram-positive bacteria, B. 
subtilis, S. aureus and M. luteus as well as 
few fungal pathogens, A. niger, A. flavus, C. 
albicans, F. semitectum, Rhizoctonia solani 
and Botrytis cinera. 
- A161 inhibited the growth of the Gram-
negative bacteria 
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Table 4 (cont.) Bioactive substances from actinomycetes with antibacterial and 
antifungal activities 
 
Investigator Actinomycetes Substances produced/inhibition. 
Duraipandiyan 
et al., 2010 
Actinomycetes from 
soil of Himalaya 
-   ERIH-44 showed both antibacterial and 
antifungal activities.  
-   The antimicrobial activity was tested 
against bacteria and fungi, and showed 
following MIC values: B. subtilis 
(<15.62 µg/ml), S. aureus (<15.62 
µg/ml), E. coli (125 µg/ml) and P. 
aeruginosa (500 µg/ml), B. cinerea (500 
µg/ml) and Trichophyton 
mentagrophytes (1000 µg/ml). 
Aouiche et al., 
2012 
Streptomyces sp. 
PAL111 
-  Isolate PAL111 showed a strong 
activity against C. albicans, filamentous 
fungi, Gram-positive and Gram-negative 
bacteria. The MIC were observed 
between 2 and 20 µg/ml for yeast, 10 
and 50 µg/ml for filamentous fungi, 
2and 10 µg/ml for Gram-positive and 20 
and 75 µg/ml for Gram-negative 
bacteria. 
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1.2.2.2.3.2 Substances that inhibit the growth of cancer cells 
 
In addition to the ability to produce antimicrobial substances, actinomycetes 
can also produce substances capable of inhibiting the growth of cancer cells and also 
chemicals with antioxidant property as shown in Table 5. 
 
Table 5 Bioactive substances from actinomycetes that inhibit the growth of cancer 
cells 
 
Investigator Actinomycetes Substances produced/inhibition. 
Hardt et al., 
2000 
 
Actinomycetes 
strain CNH-099 
-   A new substance neomarinone and 3 
derivatives: isomarinone, 
hydroxydebromomarinone and 
methoxydebromomarinone inhibited the 
growth of colon cancer cells (HCT-116 
colon carcinoma) with IC50 of 8.0 µg/ml. 
Woo et al., 2002 
Streptomyces sp. 
strain AP77 
-  The heterologous protein consisting of 
SAP1, SAP2, and SAP3 were toxic to 
Porphyra yezoensis at concentrations 
greater than 700.0. µg/ml in 24 hours and  
toxic to dermal fibroblasts at the 
concentration of 250.0 µg/ml in 12 hours. 
Shin et al., 2003 Nocardioforms 
-  MKN-349A a new type of cyclic tetra 
peptide inhibited the growth of cancer 
cells (leukemia cell line K-562) with an 
LC50 of less than 0.05 µg/ml. 
Mitchell et al., 
2004 
Streptomyces 
aureoverticillatus 
-   Aureoverticillactam inhibited the growth 
of cancer cells: HT-29, B16-F10, Jurkat 
cells with an EC50 of 3.6±2.6, 2.2±0.9 
and 2.3±1.1  M, respectively. 
17 
 
Table 5 (Cont.) Bioactive substances from actinomycetes that inhibit the growth of 
cancer cells 
 
Investigator Actinomycetes Substances produced/inhibition. 
Dasari  et al., 
2012 
Amycolatopsis alba 
var. nov. DVR D4 
-   Cytotoxic compound of DVR D4, which 
was identified as 1(10-aminidecyl) 
pyridinium salt antibiotic. 
-   The compound showed potent cytotoxic 
activity against cancer cell line of cervix 
(HeLa), breast (MCF7) and brain (U87 
MG) and exhibited antibacterial activities 
against Gram-positive and Gram-
negative bacteria. 
Ravikumar et 
al., 2012 
Actinomycetes 
isolates 
- ACT01 and ACT02 showed the IC50 
value with 10.13±0.92 and 22.34±5.82 
µg/ml, respectively for MCF-7 cell line 
at 48 h, and ACT01 showed the 
minimum level of IC50 value 
(18.54±2.49 µg/ml) with MDA-MB-231 
cell line. 
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1.2.3 Characteristic of actinomycetes 
 
Actinomycetes are Gram-positive bacteria in the phylum 
Actinobacteria, class Actinobacteria, and order Actinomycetales (Miyadoh, 1997). 
They have been placed in a group of bacteria since they have no nuclear membrane 
and mitochondria (Goodfellow and Brand, 1980). They are classified as true bacteria 
because their major cell wall components contain layers of peptidoglycan, muramic 
acid, diaminopimeric acid but no chitin and cellulose. Actinomycetes have a 
filamentous and branching growth pattern resulting in an extensive colony or 
mycelium (aerial mycelium and substrate mycelium). The mycelium in some species 
may break apart to form rod- or coccoid-shaped forms. Many genera also form spores; 
the sporangia, or spore chain may be found on aerial hyphae, on the colony surface, or 
free within the environment. Most members are aerobes but a few, such as 
Actinomyces israelii, can grow under anaerobic conditions. Morphological 
characteristics are important for the classification of actinomycetes in the Family to 
the Genus levels. In addition, chemotaxonomy such as the analysis of amino acids and 
type of sugar, key components of the cell wall is also important in their classification. 
The analyses of 16S and 23S ribosomal RNA genes are helpful in identification in the 
species level. Another important characteristic of actinomycetes is the high percentage 
ratio of guanine and cytosine in DNA (>55%), while other Gram-positive bacteria 
such as Bacillus, Clostridium, Staphylococcus and Streptococcus are less than 50, 
(Glazer and Nikaido, 1994).  
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Streptomycetes are the most widely studied and well known genus of 
the actinomycete family. Their life cycle shown in Figure 4 starts from spore 
germination and growth of the substrate mycelium. Substrate mycelium utilizes 
nutrients in the medium for growth and develops of aerial mycelium. After maturation, 
aerial mycelium develops spores. In most actinomycetes, secondary metabolites are 
produced during the sporulation phase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 The life cycle of actinomycetes.  
Source: Thong-Oon (2008). 
 
The growth of actinomycetes on the solid (surface culture) and in liquid 
(submerged culture) culture media has different characteristics. In liquid medium cells 
grow as a group of mycelium, called pellets, but some actinomycetes, such as 
Nocardia coralline when grown in liquid culture medium with shaking become rod 
shaped and can multiply by binary fission and fragmentation, while the growth on the 
agar surface with the same components as the liquid medium is produced in a 
filamentous form with branching mycelium and fragmentation when aging (Thong-
Oon, 2008). 
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1.2.3.1 The morphology of the actinomycetes 
1.2.3.1.1 The mycelial structure (Vobis, 1997) 
 
The mycelium of actinomycetes is similar to fungi but smaller, 0.4 to 1.2  m in 
size and septate with branching at the end of each mycelium. The ultrastructure of 
actinomycetes is not fundamentally different from bacteria (Figure 5). The main 
structures in the mycelium cytoplasm contains DNA, ribosomes, and others organelles 
such as fat or polysaccharides, polyphosphates. Mesosomes are derived from the 
cytoplasmic membrane and are adjacent to the cell wall. The cell wall of the mycelium 
is a single layer about 10-20 nm thick. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Cytological organization of the aerial mycelium of actinomycetes.  
             cp: cytoplasm   pm: plasmamembrane 
cw: cell wall              me: mesosome 
se:  septum              ri:   ribosome 
DNA: nucleoid region            re: reserve material       
Source: Vobis (1997)  
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1.2.3.1.2 Colony development (Vobis, 1997) 
 
   Spores or mycelial fragment of certain parts of the colony of origin 
(Figure 6A) are developed as a dietary mycelium (substrate mycelium) (Figure 6B), 
then the mycelia are grown through the air (aerial mycelium) (Figure 6C), which is a 
part directly exposed to the air and produces spore. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Development of colony of actinomycetes  
 A: spores or mycelial fragment of certain parts of the colony of origin 
 B: substrate mycelium 
 C: aerial mycelium 
Source: Vobis (1997)  
 
   The colonies of actinomyetes are very different in different species. 
Streptomyces has tough, leathery, frequently pigmented colonies and has filamentous 
growth with aerial mycelium and substrate mycelium and produces an earthy odor. 
Micromonospora growing on solid media forms only substrate mycelium, which is 
raised and folded with areas of different colors. Nocardia colonies have a variable 
appearance, but most species appear to have aerial hyphae when viewed with a 
dissecting microscope, particularly when they have been grown on nutritionally 
limiting media. The color of actinomycete colony may be white, yellow, pink, red, 
brown and black. 
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1.2.3.1.3 Spore types (Vobis, 1997) 
Actinomycete spores are formed either by subdivision of existing 
hyphae, by fragmentation or swelling or by endogenous spore formation. The hyphae 
that subdivide into spores can be sheathless or have a sheath, which partly remains on 
the spores after fragmentation. Spores are formed as single spore, spore chains, and 
spore in a sporangium.  
 
(1.)      Single spore 
 
            Single spore or the monosporous type is found in the genera 
Thermomonospora, Micromonospora, and Saccharomonospora.  Single spores 
are produced on branched and unbranched aerial mycelium as shown in Figure 
7.  
 
 
 
 
 
 
 
 
 
 
Figure 7  Single spore production  
               A. Micromonospora  
               B. Thermommonospora  
               C. Saccharomonospora  
Source: Vobis (1997)  
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(2.) Spore chains 
 
             Most actinomycetes produce spore chains which can be divided into 
sections based on the length or the number of spores as disposrous or 
bisporous, oligosporous and polysporous (Figure 8).  
 
 
 
 
 
 
 
 
 
 
Figure 8 Dispore and oligosporous production of actinomycetes  
                      A: Disporous of Microbiospora  
                      B: Oligosporous of Nocardia brevicatena  
                      C: Oligosporous of Catellatospore  
Source: Vobis (1997)  
 
 
            Streptomyces and other actinomycetes can produce many spores called 
arthrospores. These arthrospores are similar to those produced by mitosporic 
fungi by fragmentation. Morphology of the spore chains can be used to identify 
actinomycetes. Figure 9 shows four types of long chain spores of actinomyetes. 
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Figure 9 Spore production in long chains of actinomycetes.  
                       A: Rectiflexibiles  
                       B: Retinaculiaperti  
                       C: Spira  
                       D: Verticillati  
Source: Vobis (1997)  
 
 
(3)  Spores in sporangia 
 
            Some actinomycetes produce spores in sporangia. The spore production 
in sporangia can be divided into two groups: sporangia on the mycelium 
surface and sporangia developed on aerial mycelium. 
 
(3.1) Sporangia on the mycelium surface 
In the genus Actinoplanes, sporangia are spherical with diameters of 5-
15 µm, spores are in chains and branching within sporangia. It was found that 
Ampullariella can produce sporangia on substrate mycelium in a variety of 
forms such as spheres, cylinders, etc., as shown in Figure 10, with an average 
spore width of 10 µm and 15 µm long. 
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Figure 10 Spore production within sporangia  
                      A. Actinoplanes (Ampullariella): polysporous  
                        1. globose 2. cylindrical 3. lobate 4. subglobose 5. irregular  
                     B. Pilimelia  
                        6. ovoid 7. campanulate 8. cylindrical  
                     C. Dactylosporangium: oligosporous  
                       9. claviform  
Source: Vobis (1997)  
 
 
                (3.2) Sporangia developed on aerial mycelia 
 
 Some genera produce sporangia on aerial mycelium such as 
Planomonospora and Planobispora produce cylindrical sporangia containing a 
single spore and disporous, respectively. Streptosporangium produce large 
spherical sporangia (~10  m in diameter) and the nonmotile spores or 
sporangiospores are formed by septation of coiled unbranched hyphae within 
the sporangium as shown in Figure 11 (Thong-Oon, 2008).  
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Figure 11 Sporangia developed on aerial mycelia  
             A.  Planomonospora : monosporous  
             B.  Planobispora : disporous  
             C.  Planotatraspora : tetrasporous  
             D.  Planopolyspora : polysporous  
             E.  Spirillospora : polysporous  
             F. Streptosporangium : polysporous  
Source: Vobis (1997)  
 
 
1.2.3.1.4 The principle chemical components of the actinomycetes 
 
  The chemical components of the cell wall including major wall amino 
acids and the types of sugar are the key features for the chemotaxonomy of 
actinomycetes. Cell wall types according to major amino acids can be divided into 
four types as shown in Table 6 and the sugar patterns of actinomycetes are shown in 
Table 7. 
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Table 6 Chemotaxonomic characteristics of actinomycete cell wall 
 
Type Major amino acid 
Distinguishing 
major 
constituent 
I L-Diaminopimelic acid (L-DAP) Glycine 
II meso- Diaminopimelic acid (meso-DAP) Glycine 
III meso*- Diaminopimelic acid (meso-DAP or OH-DAP) None 
IV meso- Diaminopimelic acid (meso-DAP) None 
 
*Madurose is 3-hydroxy- aminopimelic acid 
Source: William (1989)  
 
 
 
Table 7 Whole cell sugar patterns of actinomycetes  
 
Sugar 
Pattern 
Arabinose Galactose Madurose* Xylose 
A + +   
B   +  
C  No diagnostic sugar  
D +   + 
 
 *Madurose is 3-O-methyl-D-galactose  
Source: William (1989)  
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Table 8 Characteristics of the seven groups of actinomycetes  
 
Group 
Cell wall 
type 
Cell sugar 
patterns 
Mol % 
G+C 
Sporangia* 
Nocardioforms IV A 59-79 +/- 
Multilocular sporangia III B, C, D 57-75 +/- 
Actinoplanetes II D 71-73 + 
Streptomycetes I - 69-78 - 
Maduromycetes III B, C 64-74 +/- 
Thermomonospora III major C 64-73 - 
Thermoactinomycetes III C 52-55 - 
 
* +  with sporangia 
   -   no sporangia 
Source: Glazer and Nikaido (1994). 
 
 
1.2.4 Classification of actinomycetes (William, 1989) 
 
In general, the classification of actinomycetes is primarily based on 
morphology such as aerial mycelium, substrate mycelium, spores and sporangium. In 
addition, actinomycetes are divided into groups based on chemical analysis such as 
analysis of the cell wall components, analysis of the sugar components of the cell 
walls, types of phospholipid and types of menaquinone etc. Based on the morphology 
and chemical composition of cells actinomycetes can be grouped into 8 groups as 
follows: Nocardioform actinomycetes, Actinomycetes with multilocular sporangia, 
Actinoplanetes, Streptomycetes, Maduromycetes, Thermomonospora, 
Thermoactinomycetes, and other genera. Characteristics of seven groups of 
actinomycetes are shown in Table 8 and the classification actinomycetes are shown in 
Table 9. 
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1.2.4.1 Nocardioform actinomycetes 
 
Actinomycetes in this group are diverse. Most of them have branching 
mycelium that breaks up into rod-shaped or coccoid elements, some strains have aerial 
mycelium and conidia. Actinomycetes in this group are aerobic bacteria except genus 
Oerskoviae which are facultative anaerobe. Most of the nocardioforms have a type IV 
(meso-DAP) cell wall composition. Nocardia and Rhodococcus cell walls also contain 
mycolic acid and sugar pattern A (arabinose and galactose).  
 
         1.2.4.2 Actinomycetes with multilocular sporangia  
 
  Actinomycetes having multilocular sporangia include 3 genera; 
Dermatophilus, Geodermatophilus and Frankia. Geodermatophilus has a simple 
rudimentary thallus. The entire thallus becomes the sporangium when spores are 
present. The mycelia of Dermatophilus are moderate to extensively developed and are 
almost entirely converted to long multilocular sporangium. Frankia produces 
extensive filaments and sporangia are borne intercalary, terminally or on lateral 
branches. All three genera have no aerial myelia. Dermatophilus, Geodermatophilus 
have motile spores. Frankia is a nitrogen-fixing genus and in microaerophilic 
environments they produce terminal sporangium and intercalary swellings containing 
nonmotile spores. All three genera have cell wall type III. Dermatophilus has sugar 
pattern B (madurose), Geodermatophilus sugar pattern C (no diagnostic sugars) and 
Frankia may have sugar pattern B or C. 
 
1.2.4.3 Actinoplanetes 
 
     Actinomycetes in this group comprise five genera; Actinoplanes, 
Ampullariella, Pilimelia, Dactylosporangium and Micromonospora. Most of them 
have aquatic habitats and produce motile spores (zoospores) during their life cycle. 
Aerial mycelia are rarely developed or only sparse.  
Actinoplanes, Ampullariella, Pilimelia, and Dactylosporangium 
produce motile spores within sporangia or vesicles at the tip of sporangiophore on the 
surface of a substrate. Spores are formed within the sporangium by fragmentation of 
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branched or unbranched, straight or coiled sporogenous hyphae. Multisporous 
sporangia have various shapes such as cylindrical, bottle shaped, flask shaped, etc. 
Micromonospora produces nonmotile spores that are borne singly, sessile or in 
clusters. The spores are spherical, ovoid, or ellipsoidal with much-thickened wall 
layers sometimes with spiny ornamentations. This group has cell wall type II (meso-
DAP and/or 3-hydroxy-DAP) and glycine and sugar pattern D (arabinose and xylose ). 
 
1.2.4.4 Streptomycetes and related genera 
 
Actinomycetes in this group comprise five genera including 
Streptomyces, Streptoverticillium, Kineosporia, Intrasporangium and Sporichthya. 
The characteristics among members of this group are very distinctive. Sporichthya 
colonies are very small. It is suggested to use microscopic examination for their 
recognition. They have no aerial mycelium or they are very sparse.  Kineosporia 
colonies have a glistening appearance. Kineosporia, Intrasporangium and Sporichthya 
produce less aerial mycelium or no aerial mycelium. Streptomyces and 
Streptoverticillium produce a well developed mycelium and a long chain of 
arthrospores on the aerial mycelium. In Streptoverticillium, spore chains are arranged 
in a verticilliate form.  Streptomyces produce tough, leathery, frequently pigmented 
colonies with a characteristic earthy odor. The surface of the colonies is wrinkled 
when old and spores generated on the surface of the mycelium are chalky. Bacteria in 
this group have cell wall type I (L-DAP and glycine). 
 
1.2.4.5 Maduromycetes 
 
There are seven genera of actinomycetes in this group including 
sporangiate actinomycetes (Planobispora, Planomonospora, Spirillospora and 
Streptosporangium) and  actinomycetes forming paired or short chains of spores on 
aerial mycelia (Actinomadura, Microbispora, and Microtetraspora). Some species 
have motile spores such as Planobispora, Planomonospora and Spirillospora. They 
have type III cell wall (meso-DAP). Planobispora, Planomonospora, Spirillospora 
and Streptosporangium have sugar pattern B {3-O-methyl-D-galactose (madurose)} 
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while Actinomadura, Microbispora, and Microtetraspora have sugar patterns B or C 
(no diagnostic sugars). 
 
1.2.4.6 Thermomonospora and related species 
 
Actinomycetes in this group comprise 4 genera: Thermomonospora, 
Actinosynnema, Nocardiopsis, and Streptoalloteichus. They have common cell wall 
type III (meso-DAP), no diagnostic sugars (type C), and no mycolic acid.  Their 
morphologies are diverse. Thermomonospora is thermophilic (can grow in the 
temperature range 40-48oC) and produces single spores on aerial, and occasionally on 
substrate mycelium. Actinosynnema and Nocardiopsis produce spores in chain but 
Actinosynnema forms synnemata on the agar surface whereas Nocardiopsis has a well 
developed substrate mycelium that tends to be fragmented into coccoid and bacillary 
elements. Streptoalloteichus produces spores in a sporangium. 
 
1.2.4.7 Thermoactinomycetes  
 
  This group comprises only one genus Thermoactinomyces. They grow 
well at high temperatures and produce single endospores. Their G+C content is lower 
than those of other actinomycetes. Their 16S rDNA sequences are closely related to 
Bacillus but they produce a well-developed mycelium, therefore they are still linked 
together with other actinomycetes. All species produce aerial mycelia. T. dichotomous 
produces a yellow colony and others are white. They have cell wall type III (meso-
DAP), but without diagnostic sugars and amino acids.  
 
 
1.2.4.8 Other genera 
 
Actinomycetes in this group are not correlated with other groups. There 
are four genera comprising. Glycomyces, Kibdelosporangium, Kitasatosporia and 
Saccharothrix. All genera produce aerial mycelia.  
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Table 9 Classification of actinomycetes in the Order Actinomycetales  
 
Order Families Genera 
   
Actinomycetaceae  
Micrococcaceae  
Bogoriellaceae Bogoriella 
Rarobateraceae Rarobacter 
Sanguibacteriaceae Sanguibacter 
Brevibacteriaceae Brevibacterium 
Cellulomonadeceae Cellulomonas 
Oerskovia 
Dermabacteriaceae Dermabacteria 
Brachybacterium 
Dermatophilaceae Dermatophilus 
Dermacoccaceae  
Intrasporangiaceae  
Jonesiaceaea Jonesia 
Microbacteraceae  
Beutenberggiaceae Beutenberggia 
Promicromonosporaceae Promicromonospora 
Corynebacteriaceae Corynebacterium 
Dietziaceae Dietzia 
Gordoniaceae Gordonia 
Skermania 
Nocardiaceae Nocardia 
Rhodococcus 
Williumsiaceae Williumsia 
Actinomycetales 
Micromonosporaceae  
   
 
Source: Stackbrandt et al. (1997) 
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Table 9 (Cont.) Classification of actinomycetes in Order Actinomycetales 
 
 
Order Families Genera 
   
Actinomycetales Propionibacteriaceae  
Nocardioidaceae  
Pseudonocardioidaceae  
Actinosynnemataceae  
Streptomycetaceae  
Streptosporangiaceae  
Nocardiopsaceae Nocardiopsis 
Thermobofoda 
Thermomonosporaceae  
Frankiaceae Frankia 
Geodermatophilaceae  
Microspheraceae  
Sporichthyaceae Sporichthya 
Acidothermaceae Acidothermus 
Kinesporiaceae  
 
Glycomycetaceae Glycomyces 
   
 
Source : Stackbrandt et al. (1997)  
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1.3 Objectives of this research 
  
1)    To isolate actinomycetes from soils and screen for their ability to 
produce antimicrobial substances against human pathogens by a cross 
streak technique and hyphal growth inhibition. 
2)   To cultivate the selected active actinomycetes in broth medium for 
chemical extraction of active substances. 
3)   To determine the minimal inhibitory concentration (MIC), minimal 
bactericidal concentration (MBC) or minimal fungicidal concentration 
(MFC) of the crude extracts. 
4)   To determine the effect of the best active crude extracts on the targeted 
microorganisms by scanning electron microscopy. 
5)   To optimize the culture conditions for the production of active 
metabolites of the top two active actinomycetes. 
6)   To identify the best active actinomycetes. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
 
 
 
2.1 Materials 
2.1.1 Sampling of soil samples 
 
Soil samples were collected from ten locations in the south of Thailand  
(Table 10). 
 
Table 10 Sources of soil samples for actinomycetes isolation 
 
Collecting site Province 
      
       Pak Panang Basin Region 
         
        Nakhon Si Thammarat 
        Karom Waterfall         Nakhon Si Thammarat 
        Khao Maha Chai          Nakhon Si Thammarat 
        Lam Talumphuk         Nakhon Si Thammarat 
        Ton Nga Chang Waterfall 
        Songkhla 
        Songkhla Lake         Songkhla 
        Khao Chaison          Phattalung 
        Kanghurae         Phattalung 
        Klong Palean         Trang 
        Khao Phap Pha          Trang 
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2.1.2 Microorganisms 
 
Tested bacteria 
- Staphylococcus aureus ATCC 25923  
- Methicillin-resistant Staphylococcus aureus SK1 (MRSA-SK1)  
   isolated from patient by Pathology Department, Faculty of Medicine,  
   Prince of Songkla University  
- Escherichia coli ATCC 25922  
- Pseudomonas aeruginosa ATCC 27853 
 
Tested fungi 
  Yeasts 
- Candida albicans ATCC 90028 
- Candida albicans NCPF 3153 
- Cryptococcus neoformans ATCC 90112 
- Cryptococcus neoformans ATCC 90113 
 
  Filamentous fungi  
- Microsporum gypseum SH-MU4 isolated from patient by  
  Microbiology Department, Faculty of Medicine Siriraj Hospital,  
  Mahidol University   
- Penicillium marneffei isolated from patient by Pathology Department, 
Faculty of Medicine, Prince of Songkla University 
 
Actinomycetes  
- 40 new isolates from soils from ten locations in southern Thailand 
(Table 12). 
- 60 isolates provided by Assoc. Prof. Dr. Vasun Petcharat, Department 
of Pest Management, Faculty of Natural Resources, Prince of Songkla 
University. 
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2.1.3 Chemicals  
- 0.85% NaCl, normal saline solution (NSS) 
- Lacto phenol cotton blue  
- McFarland Standard      
- Dimethyl sulfoxide (DMSO)   (Merck) 
- Resazurin      (Sigma Chemical Co., USA)  
 
2.1.4 Media 
- Mueller-Hinton agar (MHA)   (Difco) 
- Sabouraud dextrose broth (SDB)   (Difco) 
- Sabouraud dextrose agar (SDA)   (Difco) 
- Nutrient broth (NB)     (Difco) 
- Nutrient agar (NA)     (Difco) 
- RPMI-1640 without phenol-red (pH7)  (Sigma Chemical Co., USA) 
- Yeast extract-malt extract agar (ISP-2)  (Appendix)   
- Yeast extract-malt extract broth   (Appendix) 
- Actinomycete Isolation Agar (AIA)   (Difco) 
 
2.1.5 Antibiotics 
- Vancomycin      (Fujisawa, USA) 
- Gentamicin      (Oxoid) 
- Amphotericin B     (Bristol-Myer Squibb Co., USA) 
- Miconazole      (Sigma Chemical Co., USA) 
 
2.1.6 Equipment 
- Autoclave      (Tomy, SS-320) 
- Hot air oven      (Sanyo, MOV212) 
- Centrifuge      (Hermle) 
- Balance      (Diethelm & Co., Ltd) 
- pH meter      (Beckman, 360) 
- Laminar flow     (Hotpack, 527044) 
- Vortex mixer     (Lab-Line, 1297) 
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- Microscope      (Olympus, CX31) 
- Stereo zoom microscope    (Olympus, SZ40) 
- Water bath      (Memmert, W350) 
 
 
2.2 Methods 
 
2.2.1 Sample Collection (adapted from Parungao et al., 2007)  
 
 Soil samples were collected from ten different natural locations such as 
mountain areas, waterfalls, mangroves etc. From each location, five soil samples were 
collected from 10 to 15 cm below the surface. Each sample was placed in a small pre-
labeled plastic bag which was tightly sealed. Soil samples were air dried for one week 
at the Mycology Laboratory, Department of Microbiology, Faculty of Science, Prince 
of Songkla University before isolation.  
 
2.2.2 Isolation of Actinomycetes 
 
 Soil samples were air-dried and ground into powder. One gram of each 
sample was suspended in 9 ml sterile distilled water and serially diluted to 10-4. Then 
0.1 ml of the dilutions 10-2 to 10-4 were spread onto Actinomycete Isolation Agar 
(AIA) and incubated at room temperature (RT) for one week. After incubation, 
actinomycete isolates were distinguished from other microbial colonies by their 
morphological characteristics such as tough, leathery colonies which are partially 
submerged into the agar (Jensen et al., 1991). The pure isolates were maintained on 
yeast extract-malt extract (YME) agar slants at RT (Parungao et al., 2007). 
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2.2.3 Antimicrobial testing of actinomycetes by cross streak technique 
 
One hundred isolates of actinomycetes were tested for antimicrobial 
activity against bacteria and yeasts by cross streak technique. Each actinomycete 
isolate was cultured in YME broth on a rotary shaker at 120 rpm at 30oC for 1 week. 
One loop of each isolate was streaked along the center of YME agar and incubated at 
RT for 4 weeks or until sporulation occured. Then one loop of each tested strain was 
streaked on YME agar at the edge of the actinomycetes streak as shown in Figure 12. 
Plates were incubated at 35oC for 24 h for bacteria and C. albicans. After measuring 
the inhibition zones for bacteria and C. albicans, plates were further incubated at room 
temperature for 48 h and measured the inhibition zones for C. neoformans (Sawasdee, 
2008).  
 
 
 
 
 
 
 
 
 
 
 
Figure 12 Diagram of antimicrobial testing of actinomycetes by cross streak technique 
 
 
 
 
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 CA28 = Candida albicans ATCC 90028 
Actinomycete streak 
SA 
MRSA 
EC 
PA 
CA 28 
CA 53 
CN 12 
CN13 
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2.2.4 Hyphal inhibition by actinomycetes (adapted from Jimenez-Esquilin and 
Roane, 2005) 
 
 Each actinomycete isolate was streaked onto one half of YME agar 
plate and incubated at RT for 4 weeks or until sporulation occurred. Then a mycelial 
plug from an actively growing fungal colony (M. gypseum or P. marneffei) was placed 
about 0.5 cm from the edge of actinomycete streak (Figure 13) and incubated at RT for 
7 days. Fungal inhibition was observed everyday. The radii of the fungal colony on the 
test and control plates were then measured. The percentage of hyphal growth 
inhibition was calculated using the following formula: 
 
                         % inhibition = 100-( 2
2 100
r
R  )    (Gamliel et al., 1989) 
 
                   R = radius of treated colony, r = radius of the control colony  
 
  
 
 
 
 
  
 
 
Figure 13 Diagram of fungal inhibition test by actinomycetes 
 
 
0.5 cm Tested fungus 
Actinomycete streak 
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2.2.5 Actinomycete fermentation and culture filtrate extraction (adapted from 
Duangsook, 2010) 
 
Actinomycete isolates that showed inhibition zone over 25 mm and hyphal 
growth inhibition over 80% were selected and cultured in YME broth for extraction of 
bioactive compounds. Each active actinomycete isolate was cultured in ISP-2 broth on a 
rotary shaker at 120 rpm at 30oC for 1 week. Then 108 spore/ml of the actinomycete 
suspension was added to 100 ml ISP-2 broth in flat bottles and incubated at RT for 6 
weeks. 
The culture filtrate of actinomycetes was extracted three times with an 
equal volume of ethyl acetate (EtOAc) in a separating funnel. The EtOAc layer was 
dried over anhydrous sodium sulfate (Na2SO4) and evaporated to dryness under 
reduced pressure at 45oC using a rotary vacuum evaporator to obtain a crude BE 
extract. The mycelia were extracted with 500 ml of methanol (MeOH) for 2 days. The 
aqueous MeOH layer was concentrated under reduced pressure. H2O (50 ml) was 
added to the extract and the mixture was then mixed with hexane (100 ml). The 
aqueous layer was then extracted three times with an equal volume of EtOAc. The 
hexane extract and the combined EtOAc extracts were dried over Na2SO4 and 
evaporated to dryness under reduced pressure at 45°C using a rotary vacuum 
evaporator to give CH and CE extracts, respectively (Figure 14).  
 
 
 
 
 
 
 
 
 
Figure 14 Actinomycete fermentation and crude extracts from actinomycete  
 A : Actinomycete fermentation in flat bottles 
 B : Crude extracts 
A B 
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2.2.6 Screening for antimicrobial activities 
2.2.6.1 Inoculum preparation 
 
Tested bacteria (S. aureus ATCC 25923, MRSA-SK1, E. coli ATCC 
25922, P. aeruginosa ATCC 27853) were streaked onto nutrient agar (NA) and 
incubated at 35oC for 18-24 h C. albicans and C. neoformans were streaked onto 
Sabouraud dextrose agar (SDA) and incubated at 35oC for 18-24 h and at RT for 48 h, 
respectively. Three to five single colonies of bacteria were picked into nutrient broth 
(NB), of C. albicans and C. neoformans were picked into RPMI-1640, and both 
incubated at 35oC for 3-5 h while shaking at 150 rpm. After incubation, sterile normal 
saline solution (NSS) was used to adjust the turbidity to equal the 0.5 McFarland 
standard (MF) for bacteria and the 2.0 MF for yeasts. Agar plugs of M. gypseum and 
P. marneffei were placed on SDA and incubated at 25oC for 2-3 weeks or until it 
produced spores. The spores were collected by scraping with a sterile glass beads and 
were suspended with NSS. The spore suspension was adjusted to 4 x 103 – 5 x 104 
CFU/ml using a hemacytometer. 
 
2.2.6.2 Testing for antibacterial activity (modification of CLSI M7-A4, 2002a) 
 
 Actinomycete crude extracts were dissolved in dimethyl sulfoxide 
(DMSO) to prepare stock solutions of 100 mg/ml, and stored at -20oC until used. 
DMSO was used to dilute to 1:10 and Mueller-Hinton broth (MHB) for further 
dilutions of 1:25 to obtain concentrations of 400 µg/ml. Triplicate 50 µl samples of 
crude extracts (400 µg/ml) were placed into sterile 96-well microtiter plates. The 
bacterial inocula (0.5 MF) were diluted 1:200 (~106 CFU/ml) using MHB and 50 µl 
added to the top well in each row so that the final concentration of crude extract was 
then 200 µg/ml. Plates were incubated at 35oC for 15 h, then 10 µl of resazurin 
indicator (0.18%) was added to each well and examined after incubation for 2-3 h at 
35oC for the completed incubation time (Sarker et al., 2007). 
Vancomycin and gentamicin at final concentrations of 10 µg/ml were 
used as standard antibacterial agents for positive inhibitory controls against           
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Gram-positive and Gram-negative bacteria, respectively and for comparisons with the 
extracts.  
2.2.6.3 Testing for antifungal activity (yeasts) (modification of CLSI M27- 
              A2, 2002b) 
 
Yeasts were tested in a similar way to bacteria but using RPMI-1640 
medium. Microtiter plates were incubated at 35oC for 24 h for C. albicans and 48 h at 
RT for C. neoformans, then 10 µl resazurin indicator (0.18%) was added to each well 
and examined after incubation for 5 h at 35oC (adapted from Sarker et al., 2007). 
Amphotericin B at a final concentration of 10 µg/ml was used as a 
positive inhibitory control and for comparison with the extracts. 
 
2.2.6.4 Testing for antifungal activity (filamentous fungi) (modification of   
              CLSI M38-A, 2002c) 
 
Filamentous fungi (M. gypseum and P. marneffei) were tested in a 
similar way to bacteria but using RPMI-1640 medium. Microtiter plates were 
incubated at 25oC for 6 days, then 10 µl resazurin indicator (0.18%) was added to each 
well and incubated for one day at 25oC. 
Miconazole (32 µg/ml) was used as the standard antifungal drug for M. 
gypseum and for comparison with the extracts. 
Amphotericin B (10 µg/ml) was used as a positive inhibitory control for 
P. marneffei and for comparison with the extracts. 
 
Interpretation of the screening results 
 
After incubation, a blue or purple color of the wells indicated inhibition 
of growth (positive result) and a pink color meant growth had occurred (negative 
result). 
Crude extracts shown to have antimicrobial activity were assayed 
further for their minimal inhibitory concentrations (MIC), minimal bactericidal 
concentrations (MBC) and minimal fungicidal concentrations (MFC). 
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2.2.6.5 Determination of minimal inhibitory concentration (MIC), minimal   
 bactericidal concentration (MBC) and minimal fungicidal 
 concentration (MFC) of actinomycete crude extracts 
 
 The MICs of crude extracts were determined by a broth microdilution 
method according to a modification of CLSI M7-A4 (CLSI, 2002a) against bacteria,   
CLSI M27-A2 (CLSI, 2002b) against yeasts and CLSI M38-A (CLSI, 2002c) against 
filamentous fungi. Crude extracts were diluted using the serial dilution method 
starting with final concentrations of 128, and diluting to 64, 32, 16, 8, 4, 2, 1, 0.5 and 
0.25 µg/ml, each tested in triplicate. 
 After incubation under appropriate conditions, the lowest concentration 
of extract that inhibited growth (blue or purple color) was recorded as the MIC.  
 The MBCs and the MFCs of actinomycete crude extracts were 
determined by the streaking method. Concentrations of crude extract less dilute than 
the MIC and the MIC were streaked onto NA plate for bacteria and SDA plates for 
yeasts and filamentous fungi. Plates were incubated under appropriate conditions and 
the lowest concentration of extract that killed organisms (no growth) was recorded as 
the MBC or MFC.  
 
2.2.7 Effect of crude extract on target cells detected by scanning electron 
microscopy (SEM) 
 
 Tested bacteria (S. aureus ATCC 25923 and MRSA-SK1) were 
streaked onto MHA and incubated at 35oC for 24 h. Three to five single colonies of 
bacteria were picked into MHB and incubated at 35oC for 24 h and centrifuged at 
5,000 rpm, 5 min. Cells of bacteria were resuspended in MHB (10 ml) and treated with 
the extracts at various concentrations (MIC, 2MIC and 4MIC), incubated at 35oC for 
18 h. Cells of bacteria treated with 1% DMSO were used as control. The cells were 
collected by centrifugation and washed with the phosphate buffer saline (PBS) 3 
times. The samples were fixed in 2.5% glutaraldehyde in PBS for 1 h, then washed 
with PBS 3 times, post fixed in 1% osmium tetroxide  for 1 h, washed with sterile 
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water 3 times and dehydrated with alcohol series (50%, 70%, 80%, 90% and 100% of 
ethanol) before processing for electron microscopy at The Scientific Equipment 
Center, Prince of Songkla University. 
 
2.2.8 Optimization of antifungal metabolite production (modification of 
Augustine et al., 2005) 
 
2.2.8.1 Agitation: comparison between shaking and static conditions. 
 
A spore suspension of actinomycetes was prepared in distilled water 
from cultures grown on ISP-2 medium. The suspension was added to 100 ml ISP-2 
broth in flat bottles to obtain about 108 spores/ml of the liquid medium and incubated 
at RT for 5 weeks. Actinomycete inocula were added into flasks containing 100 ml of 
ISP-2, pH7 broth and incubated statically and on a rotary shaker at 200 rpm at 30oC 
for 5 weeks. Culture filtrates were harvested every week for antimicrobial activity 
detection by the agar-well diffusion and the biomass measurement  
 
2.2.8.1.1 The agar-well diffusion 
 
Tested bacterial suspensions (0.5 MF) were spread onto MHA. Holes 
(diameter of 6 mm) were then punched in the agar and filled with 80 µl of culture 
filtrates. The plates were incubated at 37°C for 18-24 h. The diameter of the zones of 
complete inhibition was measured to the nearest whole millimeter (Pandey et al., 
2004).  
  
2.2.8.1.2 The biomass measurement 
 
The biomass of actinomycetes was separated from the culture filtrate by 
means of centrifugation. The biomass was transferred to a pre-weighed dry filter paper 
using a clean spatula and then placed in an oven at 55oC overnight to reach a fixed 
weight (Singh et al., 2009). 
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2.2.8.2 Temperature 
 
Actinomycete inocula (described in 2.2.8.1) were added to flat bottles 
containing 100 ml of ISP-2 broth, pH7 and incubated at different temperatures (25, 30 
and 35oC) under static condition for 5 weeks and culture filtrates were harvested every 
week to check for antimicrobial activity by the agar-well diffusion and the biomass 
measurement  (described in 2.2.8.1.1 and 2.2.8.1.2).   
 
2.2.8.3 pH  
 
The initial pH of the ISP-2 media was adjusted to 6, 7 and 8. 
Actinomycete inocula (described in 2.2.8.1) were added to flat bottles containing 100 
ml of ISP-2 broth and incubated under static conditions, temperature described in 
2.2.8.2 for 5 weeks and culture filtrates were harvested every week to check for 
antimicrobial activity by the agar-well diffusion and the biomass measurement 
(described in 2.2.8.1.1 and 2.2.8.1.2).   
 
 
2.2.9. Identification of actinomycetes 
 
 Actinomycetes were identified by morphological characteristics and 
molecular technique (16S rDNA). 
 
2.2.9.1 Morphological characteristics 
 
All morphological characters were observed on ISP-2 agar according to 
Taddei et al. (2006) as follows: 
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2.2.9.1.1 Macroscopic morphology 
 
The mass color of mature sporulating aerial mycelium was observed 
following growth on ISP-2 plates. The aerial mass color was classified according to 
the Bergey's Manual of Systematic Bacteriology (Locci, 1989) in the following color 
series: gray, white, red, yellow, green, blue, and violet. Distinctive colors of the 
substrate mycelium were also recorded. The observed colors were: beige, black, blue, 
biscuit, brown, ivory, olive, orange, purple, pink, red, red-violet, tan, violet-purple, 
yellow, and yellow-greenish. 
 
2.2.9.1.2 Microscopic morphology  
 
 The microscopic characterization was done by cover slip culture 
method in YME medium incubated at 28°C and observed after 30 days. According to 
the shape of the spore chains observed under light microscopy, the isolates were 
grouped as follows: Rectus-Flexibilis (RF), spores in straight or flexuous chains, and 
Spira (S), spore chains in the form of short gnarled or compact coils or extended, long 
and open coils. 
 
2.2.9.2 Molecular identification 
 
Selected potential isolates were identified based on the analysis of 16S 
rDNA sequences. DNA extraction, PCR amplification and DNA sequencing were 
done by the KU Vector, Kasetsart University as the followings: 
 
2.2.9.2.1 Actinomycete DNA extraction 
 
 Actinomycetes were grown on an ISP-2 plate at RT for 3 to 4 weeks.  
The DNA of each isolate was extracted by suspending some colonies of actinomycetes 
in 400 µl of TE buffer, and 8 µl of lysozyme (50 mg/ml) in a microtube. The mixture 
was agitated and incubated at 37oC for 30 min. Then 4 µl of proteinase K (20 mg/ml), 
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20 µl of 10%SDS and 4 µl of RNase A (100 mg/ml) were added. The mixture was 
mixed together and incubated at 37oC for 30 min. After that, 70 µl of 5M NaCl, 55 µl 
of 10%CTAB (10%CTAB/0.7M NaCl) were added and incubated at 65 oC for 10 min. 
Then an equal volume of chloroform was added and centrifuged at 15,000 rpm, RT for 
5 min. This step was repeated twice. The supernatant was transferred to a new 
microtube, added an equal volume of phenol/chloroform and centrifuged at 15,000 
rpm, RT for 5 min.  The supernatant was transferred to a new microtube, then 
isopropanal was added and centrifuged at 8,000 rpm, RT for 2 min. DNA pellet was 
washed twice with 1 ml of 70% ethanol and centrifuged at 8,000 rpm for 1 min. After 
drying DNA pellet was resuspended in 20 µl of water or TE buffer for PCR 
amplification. 
 
2.2.9.2.2 PCR amplification  
 
 Target region of the 16S rDNA was amplified using 27F and 1389 
primers listed in Table 11. 
 
Table 11 Primers used for the polymerase chain reaction (PCR) and DNA sequencing 
 
Primers Sequence (5’-3’) 
PCR 27F AGA GTT TGA TCM TGG CTC AG 
PCR 1389R ACG GGC GGT GTG TAC AAG 
DNA 
sequencing 
520F GT GCC AGC MGC CGC GG 
 
Note: M represents A or C 
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PCR mixture  
 
10 X Ex-Taq Buffer    1.5 µl  
25 mM dNTP mix    1.2  µl  
10 pmol/µl Forward primer ( 27F)  1.5  µl  
10 pmol/µl  Reverse primer ( 1398R)            1.5 µl  
Ex-Taq polymerase     0.075  µl  
Nanopure water    8.225 µl 
DNA template (100 ng/µl)                   1.0  µl 
Total volume                15.0  l 
 
 
PCR profiles for amplification: 
 
The PCR profile for primers 27F and 1389R 
95 oC   1   min 
            95 oC   20 s  
           50 oC   30 s                   35 cycles 
           72 oC   2   min 
           72 oC   4   min 
 
2.2.9.2.3 DNA sequencing and sequence alignment 
 
Sequencing mixture 
Nanopure water 9.0    µl 
5X sequencing buffer 2.25  µl 
520F primer 0.75  µl 
Ready reaction mix 1.5    µl 
DNA template 1.5    µl 
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The PCR profile for primer 520F 
            96 oC   1   min 
96 oC   10 s 
            50 oC   5   s                   25 cycles 
            60 oC   4   min 
 
 The 16S rDNA sequences were then compared with GenBank using 
BLASTN program. Sequences of the selected actinomycetes and other sequences 
obtained from the GenBank database were aligned by ClustalW (Thompson et al., 
1994). Manual gap adjustments were made to improve the alignments. The tree 
construction procedure was performed in PAUP* 4.0b10 in Window versions 
(Swofford, 2002). Maximum Parsimony (MP) was conducted using heuristic searches 
as implemented in PAUP* 4.0b10, with the default options method. Clade stability 
was assessed in a bootstrap analysis with 1,000 replicates, random sequence additions 
with maxtrees set to 1,000 and other default parameters as implemented in PAUP* 
4.0b10. Neighbor joining (NJ) tree was constructed based on the total character 
differences and bootstrap values were calculated from 1,000 replicates using PAUP* 
4.0b10. 
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CHAPTER 3 
 
RESULTS 
 
 
 
3.1. Actinomycetes isolation 
 
A total of 100 actinomycetes isolates were included in this study. Forty 
isolates (ACK1-55) with different morphotypes were isolated from soils from ten 
locations in the south of Thailand (Table 12) and 60 isolates (ACK56-120) having 
antifungal activity against plant pathogenic fungi were provided by Assoc. Prof. Dr. 
Vasun Petcharat, Department of Pest Management, Faculty of Natural Resources, 
Prince of Songkla University.  
 
Table 12 Numbers of actinomycetes isolated from soils from various locations in the   
south of Thailand 
 
Locations 
 
No. of isolates 
 
Code 
 
  
        Pak Panang Basin Region, Nakhon Si Thammarat                                                                  12 ACK1-21
        Karom Waterfall, Nakhon Si Thammarat                                                                  6 ACK22-28 
        Khao Maha Chai, Nakhon Si Thammarat                                                                  1 ACK29
        Lam Talumphuk, Nakhon Si Thammarat                                                                  1 ACK30 
        Ton Nga Chang Waterfall, Songkhla 5 ACK31-37 
        Songkhla Lake, Songkhla 4 ACK39-42 
        Khao Chaison,  Phattalung 1 ACK43 
        Kanghurae, Phattalung -  
        Klong Palean, Trang 7 ACK44-51 
        Khao Phap Pha, Trang 3 ACK53-55 
                           Total                                                                 40 
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3.2. Primary antimicrobial testing of actinomycetes by cross streak technique 
and hyphal growth inhibition  
 
A total of 100 isolates of actinomycetes were tested for antimicrobial 
activity against bacteria and yeasts by cross streak technique against human 
pathogenic bacteria: S. aureus, methicillin-resistant S. aureus (MRSA), E. coli,         
P. aeruginosa, two species of yeasts: C. neoformans and C. albicans (Figure 15) and 
hyphal growth inhibition against two species of human pathogenic filamentous fungi: 
M. gypseum and P. marneffei (Figure 16). Eighty percents of the isolates showed 
antimicrobial activity against at least one test microorganism, 48 isolates were from 
the active isolates against plant pathogenic fungi and 32 from the new isolates (Table 
13). Among them, 8% inhibited only bacteria, 12% inhibited only yeasts, 11% 
inhibited only filamentous fungi, 9% inhibited both yeasts and filamentous fungi and 
40% had both antibacterial and antifungal activities (Table 14).  
 The percentage of active actinomycetes against each test strain and the 
top 46 active actinomycetes were shown in Figure 17 and Table 15, respectively. For 
antibacterial activity, 40% of soil actinomycetes inhibited both strains of S. aureus. 
Isolate ACK18 showed the best inhibitory activity against S. aureus ATCC 25923 
(inhibition zone 30.95 mm) and ACK84 against MRSA SK1 (inhibition zone 35.17 
mm) (Table 15). Only 9% and 15% inhibited E. coli and P. aeruginosa, respectively. 
ACK108 had the best activity against E. coli (inhibition zone 32.87 mm) and 
ACK117 against P. aeruginosa (inhibition zone 33.62 mm).  
For anti-yeast activity, 30% of actinomycetes inhibited C. albicans and 
ACK26 had the best activity against both strains of C. albicans (inhibition zones 
29.27  and 32.45 mm, respectively). 49% inhibited C. neoformans and actinomycetes 
ACK60 and ACK7 had the best activity against C. neoformans ATCC90112 and 
ATCC 90113 (inhibition zones 34.37 and 28.87 mm, respectively).   
For antifungal activity against filamentous fungi, M. gypseum and P. 
marneffei, 21% inhibited M. gypseum and 41 % inhibited P. marneffei. In addition, 11 
and 30 isolates showed high inhibitory activity >80% hyphal growth inhibition and 9 
isolates strongly inhibited both fungi. 
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        Control                   ACK 26                ACK 79                 ACK 84              ACK 98 
 
Figure 15 Primary antimicrobial testing of actinomycetes by cross streak technique          
against bacteria and yeasts 
 
 
 
 
 
 
Control      ACK 9               ACK 34               ACK 58         ACK 94 
 
 
 
 
 
Control     ACK 34             ACK 110          ACK 116       ACK 117 
 
 
Figure 16 Primary antifungal testing of actinomycetes by hyphal inhibition test 
against   filamentous fungi. Upper row: Microsporum gypseum and lower 
row: Penicillium marneffei 
SA = Staphylococcus aureus ATCC 25923 CA28 = Candida albicans ATCC 90028 
MRSA = methicillin-resistant S. aureus SK1 CA53 = Candida albicans NCPF 3153 
EC = Escherichia coli ATCC 25922 CN12 = Cryptococcus  neoformans ATCC 90112 
PA = Pseudomonas  aeruginosa ATCC 27853 CN13 = Cryptococcus  neoformans ATCC 90113 
SA 
MRSA
A 
EC 
PA 
CA 28 
CA 53 
CN 12 
CN 13 
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Table 13 Distribution of actinomycetes included in this study according to their 
antimicrobial activity by cross streak technique and hyphal growth 
inhibition  
 
Origin of actinomycetes Active isolates/Total isolates tested (%) 
New isolates from soil 32/40 (80%) 
Isolates having antifungal activity  
against plant pathogenic fungi 
(From Mr. Sawai Boukaew) 
  48/60 (80%) 
Total                            80/100 (80%) 
 
 
 
Table 14 Distribution of antimicrobial spectrum of 80 active actinomycetes 
 
Activity 
% Active 
actinomycetes Antibacterial Anti-yeast 
Anti-filamentous 
fungi 
8    
12    
11    
9    
18    
9    
13    
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Figure 17 Percentages of active actinomycetes against each test microorganism  
 
 
 
 
 
 
 
 
 
 
 
 
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH- MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
38% 
21% 
9 % 
5% 
28% 30% 
47% 49% 
40% 41% 
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Table 15 Top 46 actinomycetes having antimicrobial activity against ten tested   
microorganisms by cross streak technique and hyphal growth inhibition 
test 
Inhibition  zone (mm) %  inhibition Actino- 
mycetes 
Code SA MRSA EC PA CA 28 CA 53 CN 12 CN 13 MG PM 
ACK 7 6.57 6.47 10.35 0.00 18.87 21.17 25.77 28.87 0.00 100.00 
ACK 8 24.90 33.27 0.00 0.00 23.80 28.17 18.85 21.40 0.00 100.00 
ACK 9 5.80 3.62 0.00 0.00 24.87 26.67 24.00 18.82 0.00 0.00 
ACK 18 30.95 30.87 0.00 0.00 24.32 24.00 26.75 20.97 0.00 100.00 
ACK 20 25.62 26.87 0.00 0.00 0.00 0.00 0.00 0.00 99.00 0.00 
ACK 21 30.00 34.37 0.00 0.00 0.00 5.72 0.00 0.00 0.00 0.00 
ACK 26 27.40 30.95 0.00 0.00 29.27 32.45 31.62 24.87 0.00 0.00 
ACK 36 0.00 0.00 0.00 0.00 0.00 0.00 16.75 10.75 0.00 100.00 
ACK 39 25.87 31.65 0.00 0.00 20.45 18.05 25.30 19.20 0.00 100.00 
ACK 40 0.00 0.00 0.00 0.00 0.00 0.00 27.63 23.28 0.00 0.00 
ACK 41 0.00 13.20 0.00 27.75 0.00 0.00 0.00 0.00 0.00 100.00 
ACK 43 25.37 26.77 0.00 0.00 26.65 25.60 24.05 19.55 0.00 0.00 
ACK 44 20.62 24.25 0.00 0.00 27.32 29.20 27.07 24.87 0.00 0.00 
ACK 47 19.02 25.30 0.00 0.00 8.00 11.62 14.25 10.87 100.00 100.00 
ACK 49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 69.75 90.00 
ACK 50 0.00 0.00 0.00 0.00 0.00 0.00 23.50 17.50 0.00 100.00 
ACK 51 23.82 27.25 27.27 0.00 0.00 0.00 0.00 22.00 0.00 100.00 
ACK 53 10.50 18.00 0.00 0.00 11.17 13.72 15.80 10.25 91.00 100.00 
         
  
           
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH- MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
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Table 15 (Cont.) Top 46 actinomycetes having antimicrobial activity against 
ten tested microorganisms by cross streak technique and 
hyphal growth inhibition test 
Inhibition  zone (mm) %  inhibition Actino- 
mycetes 
Code SA MRSA EC PA CA 28 CA 53 CN 12 CN 13 MG PM 
ACK 56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 87.75 
ACK 57 11.72 10.97 20.72 0.00 9.45 13.22 27.82 19.55 0.00 100.00 
ACK 58 0.00 0.00 0.00 0.00 0.00 0.00 23.65 20.43 0.00 100.00 
ACK 60 0.00 7.72 14.25 16.37 0.00 0.00 34.37 28.12 0.00 0.00 
ACK 62 0.00 0.00 0.00 0.00 0.00 0.00 24.50 17.25 0.00 90.00 
ACK 64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 100.00 
ACK 65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 100.00 
ACK 66 12.32 18.62 14.70 13.30 10.85 15.05 12.97 8.37 84.00 100.00 
ACK 67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 90.00 
ACK 70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 
ACK 71 9.73 34.82 0.00 25.50 0.00 0.00 4.50 0.00 0.00 0.00 
ACK 73 0.00 0.00 0.00 19.37 0.00 0.00 0.00 0.00 100.00 100.00 
ACK 74 0.00 0.00 0.00 0.00 10.87 14.72 15.22 8.75 96.00 100.00 
ACK 76 0.00 0.00 0.00 0.00 20.33 17.68 29.88 26.25 0.00 0.00 
ACK 83 22.25 25.70 0.00 0.00 0.00 0.00 26.32 21.75 0.00 0.00 
ACK 84 22.05 35.17 0.00 27.10 0.00 0.00 0.00 0.00 0.00 100.00 
ACK 87 10.37 0.00 0.00 0.00 9.50 12.25 16.87 13.00 0.00 100.00 
ACK 90 4.35 6.72 0.00 0.00 13.07 11.80 15.92 12.50 84.00 100.00 
           
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH- MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
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Table 15 (Cont.) Top 46 actinomycetes having antimicrobial activity against 
ten tested microorganisms by cross streak technique and 
hyphal growth inhibition test 
 
Inhibition  zone (mm) %  inhibition Actino- 
mycetes 
Code SA MRSA EC PA CA 28 CA 53 CN 12 CN 13 MG PM 
ACK 91 12.97 16.12 0.00 0.00 0.00 8.75 11.25 5.50 0.00 100.00 
ACK 102 0.00 0.00 0.00 0.00 0.00 0.00 29.10 27.00 0.00 100.00 
ACK 103 14.75 14.37 0.00 0.00 4.97 6.50 18.42 12.40 69.75 100.00 
ACK 104 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 
ACK 108 0.00 28.55 32.87 24.87 0.00 0.00 0.00 0.00 0.00 0.00 
ACK 110 0.00 0.00 0.00 28.00 0.00 0.00 0.00 0.00 82.60 78.09 
ACK 112 13.12 32.00 0.00 27.62 0.00 0.00 0.00 0.00 0.00 0.00 
ACK 116 0.00 0.00 0.00 0.00 0.00 0.00 29.25 25.62 0.00 100.00 
ACK 117 0.00 0.00 0.00 33.62 0.00 0.00 0.00 0.00 64.87 54.23 
ACK 119 0.00 0.00 0.00 28.00 0.00 0.00 0.00 0.00 0.00 0.00 
 
 
 
Top 46 actinomycetes that can inhibit each group of the tested bacteria 
and yeast from cross streak technique with inhibition zone over 25 mm and hyphal 
growth inhibition over 80% were selected for further study (Table 15). Eighteen 
isolates were from the new isolates group and 28 isolates from the active group 
against plant pathogenic fungi. Among the 18 new active isolates from soil, the 
highest number was from Pak Panang Basin Region (66.67%) followed by Karom 
Waterfall (16.67%) and Klong Palean (16.67%). 
 
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH- MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
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According to the spectrum of 80 active actinomycetes, it was found 
that most of actinomycetes inhibited three tested microorganisms (18 isolates) 
followed by 17, 13, 12, 7 and 7 isolates that inhibited 2, 6, 4, 1 and 8 tested 
microorganisms, respectively (Figure 18). Only actinomycete ACK66 inhibited all the 
tested microorganisms with high potential inhibitory activity against both filamentous 
fungi (Table 15).    
 
 
 
 
Figure 18 Number of active actinomycetes that inhibited tested microorganisms 
 
 
3.3 Screening of actinomycetes crude extracts for antimicrobial activity 
 
 The top 46 active actinomycetes were grown in ISP-2 for 6 weeks and 
their culture broths and mycelia were extracted. In total, 138 crude extracts 
comprising crude ethyl acetate extracts from culture broths (BE, 46), crude ethyl 
acetate extracts of mycelia (CE, 46) and crude hexane extracts of mycelia (CH, 46) 
were obtained for antimicrobial assay.  
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Actinomycete crude extracts at a concentration of 200 µg/ml were 
primarily tested for antimicrobial activity against the tested microorganisms by the 
colorimetric microdilution method (Figure 19). The result showed that 90 extracts 
(65.22%) from 46 active actinomycete isolates were inhibitory.   
 
 
 
 
 
Figure 19 Primary antibacterial assay by a colorimetric microdilution method at 200 
µg/ml (blue or violet color indicates an inhibitory result and pink color 
indicates growth of the test strain) 
 
  According to the types of crude extract CH provided the highest active 
extracts (34/46, 73.91%) followed by CE (31/46, 67.39%), and BE (25/46, 54.34%), 
respectively (Figure 20). CH extracts exhibited the most activity against S. aureus 
(34) and MRSA (29), followed by C. neoformans ATCC 90112 (4), P. marneffei (3), 
both strains of C. albicans (1) and P. aeruginosa (1). CE extracts exhibited the most 
activity against S. aureus (27) followed by MRSA (22), C. neoformans ATCC 90112 
(14), C. neoformans ATCC 90113 (10), both strains of C. albicans (4) and P. 
marneffei (2). BE extracts exhibited the most activity against S. aureus (21) followed 
by MRSA (19), C. neoformans ATCC 90112 (12), C. neoformans ATCC 90113 (11), 
C. albicans ATCC 90028 (5), C. albicans NCPF 3153 (4) and M. gypseum (1) (Table 
16).  
   
S. aureus MRSA E. coli P. aeruginosa 
 (BE) 
 (CE) 
(CH) 
 (BE) 
 (CE) 
(CH) 
ACK56 
ACK90 
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Figure 20 Percentage of types of active crude extracts from actinomycetes tested at 
200 µg/ml (BE = Broth EtOAc, CE = Cell EtOAc, CH = Cell Hexane) 
 
 
Table 16 Antimicrobial activity of each type of crude extracts against test   
microorganisms 
 
Test microorganisms 
Bacteria Yeasts 
Filamentous 
fungi 
Type of 
crude 
extract 
SA MRSA EC PA 
CA 
28 
CA 
53 
CN 
12 
CN 
13 
MG PM 
BE (n=46) 21 19 0 0 5 4 12 11 1 0 
CE (n=46) 27 22 0 0 4 4 14 10 0 2 
CH (n=46) 34 29 0 1 1 1 4 0 0 3 
 
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant  S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH-MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
BE = Broth EtOAc CE = Cell EtOAc 
CH = Cell Hexane    
54.34 
67.39 
73.91 
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Extracts of active actinomycetes were highly active against both strains 
of S. aureus (50.72-59.42%), followed by C. neoformans (15.11-21.58%), C. albicans 
(6.47-7.19%) and P. marneffei (5%). Only each one extract (0.72%) inhibited             
P. aeruginosa and M. gypseum. None of the extracts inhibited E. coli (Figure 21). 
 
 
 
 
 
 
Figure 21 Antimicrobial activity of actinomycete crude extracts against various 
microbes tested at 200 µg/ml 
 
  
 
 
 
 
SA = Staphylococcus aureus ATCC 25923 CA53 = Candida albicans NCPF 3153 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC 90112 
EC = Escherichia coli ATCC 25922 CN13 = Cryptococcus  neoformans ATCC 90113 
PA = Pseudomonas  aeruginosa ATCC 27853 MG = Microsporum gypseum SH- MU 4 
CA28 = Candida albicans ATCC 90028 PM = Penicillium marneffei 
50.72% 
0% 0.72% 
7.19% 6.47% 
21.58% 
15.11% 
5% 
59.42% 
0.72% 
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3.4 Determination of MIC and MBC or MFC 
 
  All extracts that showed inhibitory activity at 200 µg/ml were further 
assayed for their MICs (Figure 22), MBCs or MFCs by the colorimetric microdilution 
method. The results are shown in Table 17. 
 
 
 
 
 
 
 
 
 
a) S. aureus ATCC 25923                                   b ) MRSA-SK1 
 
 
Figure 22 Determination of MIC of crude extracts by colorimetric microdilution 
method 
 
 
3.4.1 Antibacterial activity 
 
  Of the 138 crude extracts from actinomycete isolates, 59.42% (82/138) 
and 50.72% (70/138) of extracts were active against S. aureus and MRSA (Figure 21, 
Table 16) with MIC/MBC values that ranged from 0.5-200/4->200 and 0.5-200/2-
>200 µg/ml, respectively. None of the extracts inhibited E. coli (MIC and MBC>200 
µg/ml). One extract was active against P. aeruginosa with MIC/MBC values of 
200/>200 µg/ml. Crude CH extract from ACK21 (ACK21CH) exhibited the strongest 
antibacterial activity against S. aureus and MRSA with MIC/MBC 0.5/4 and 0.5/8 
µg/ml, respectively followed by ACK20CE against S. aureus and MRSA with 
MIC/MBC 2/8 µg/ml, 0.5/2 µg/ml, respectively. This was comparable to vancomycin 
 ACK21 (BE) 
 (BE) 
 ACK21 (CE) 
 (BE) 
 ACK43 (BE) 
 (BE) 
 ACK43 (CE) 
 (BE) 
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(MIC 0.5-1 µg/ml). ACK20CE and ACK21CH at concentrations of 4 times MIC 
strongly destroyed S. aureus ATCC25923 and MRSA cells causing the leakage of 
cytoplasm and cell death as shown in the SEM in Figures 23 and 24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A : Control SA+ 1%DMSO 
 
C : SA+ ACK 20CE (4MIC) 
B : SA+ Vancomycin  (4MIC) D : SA+ ACK 21CH (4MIC) 
 
 
 
 
 
 
Figure 23 Scanning electron micrographs of the treated S. aureus ATCC 28923 (SA) 
after incubation at 35oC for 18 h 
A 
B 
C 
D 
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3.4.2 Antifungal activity 
 
  Thirty nine out of 138 extracts (28.26%) showed antifungal activity. 
The results are shown in Figure 21 and Table 16. The most active extracts (30/138, 
21.74%) were active against C. neoformans ATCC90112 with MIC/MFC values that 
ranged from 16-200/>128 µg/ml, respectively, followed by 15.22% (21/138) of the 
extracts against C. neoformans ATCC90113 with MIC and MFC value of 16–200 and 
64->200 µg/ml, respectively, and 5% against P. marneffei. Only one extract was 
active against M. gypseum (MIC/MFC 200/>200 µg/ml). Crude CH extract from 
ACK21 (ACK21CH) exhibited the strongest antifungal activity against C. albicans 
NCPF3153 with MIC/MFC 4/128 µg/ml. The antifungal drug amphotericin B had 
MIC value of 0.0625 µg/ml and MFC 2 µg/ml against C. albicans. 
A : Control MRSA+ 1%DMSO C : MRSA+ ACK 20CE (4MIC) 
B : MRSA+ Vancomycin (4MIC) D : MRSA+ ACK 21CH (4MIC) 
Figure 24 Scanning electron micrographs of the treated methicillin-resistant 
                  S. aureus SK1 (MRSA) after incubation at 35oC for 18 h 
 
 Table 17 MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic microorganisms 
 
Test    organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE           200 >200 200 >200   200 >200 
CE           200 >200 200 >200     ACK 7 
CH 200 >200 128 >128               
BE       200 >200           
CE 200 >200                 ACK 8 
CH 64 >128 128 >128               
BE 200 >200     200 >200 200 >200 200 >200 200 >200     
CE 200 >200 200 >200               ACK 18 
CH 128 >128 200 >200               
BE 4 16 1 4   200 >200 128 >128 200 >200 200 >200     
CE 2 8 0.5 2   128 >128 32 64 200 >200 200 >200     ACK 20 
CH 128 >128 128 >128 200 >200             
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic  
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE 0.5 128 1 16   200 >200 200 >200         
CE 0.5 >128 0.5 16   200 >200 200 >200         ACK 21 
CH 0.5 4 0.5 8   200 >200 4 128         
BE 64 >128 64 >128         200 >200     
ACK 26 
CH 64 >128         200 >200       
CE 128 >128                 
ACK 36 
CH 64 >128 64 >128               
ACK39 BE       200 >200 200 >200 200 >200 128 >128     
CE 128 >128 64 >128               
ACK40 
CH 64 >128 64 >128               
BE 32 >128 32 >128               
CE 16 128 16 >128               ACK 43 
CH 64 128 128 >128               
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic  
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
CE           200 >200       
ACK 44 
CH 200 >200                 
BE 200 >200         128 >128 64 >128     
CE         200 >200 64 >128 64 >128     ACK 47 
CH 200 >200 200 >200       200 >200       
CE 64 >128 64 >128       200 >200       
ACK 50 
CH 64 >128 64 >128               
BE 200 >200 200 >200               
CE 200 >200                 ACK 53 
CH 200 >200                 
BE 64 >128 128 >128               
CE 128 >128 200 >200               ACK 56 
CH 64 >128 64 >128               
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic   
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE 128 >128 200 >200       200 >200 200 >200     
CE 128 >128 200 >200               ACK 57 
CH 32 >128 64 >128       200 >200       
CE       128 >128 200 >200 64 >128 64 64     
ACK 58 
CH 128 >128 128 >128               
ACK 60 CH 128 >128                 
BE 200 >200 200 >200               
CE 200 >200 200 >200               ACK 62 
CH 128 >128 200 >200               
CE 128 >128 200 >200       200 >200       
ACK 64 
CH 32 >128 64 >128               
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic   
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE 128 >128 200 >200       16 >128 16 128     
CE 128 >128 200 >200       64 >128 64 >128     ACK 65 
CH 64 >128 64 >128               
BE 128 >128 64 >128               
CE 64 >128 64 >128               ACK 66 
CH 32 >128 32 >128               
ACK 67 CH 128 >128 200 >200               
ACK 70 CH 200 >200                 
BE 128 >128 128 >128               
CE 64 >128 64 >128       200 >200       ACK 73 
CH 128 >128 128 >128               
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic   
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE 32 >128 32 >128               
CE 200 >200 200 >200   200 >200   200 >200 200 >200   200 >200 ACK 74 
CH 200 >200 200 >200             200 >200 
BE 16 >128 64 >128               
CE 16 >128 16 >128               ACK 76 
CH 2 >128 4 >128               
CE 200 >200         200 >200 200 >200     
ACK 83 
CH 32 >128 64 >128               
BE 32 >128 64 >128       32 >128 32 >128 200 >200   
CE 128 >128 200 >200       200 >200       ACK 87 
CH 64 >128 64 >128               
BE 200 >200 200 >200               
CE 128 >128 128 >128             200 >200 ACK 90 
CH 128 >128 128 >128             200 >200 
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic   
microorganisms 
Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE 64 >128 200 >200       64 >128 64 >128     
CE 64 >128 200 >200       200 >200 200 >200     ACK 91 
CH 64 >128 128 >128               
BE 200 >200 200 >200       200 >200 200 >200     
CE 128 >128 128 >128               ACK 102 
CH 32 >128 64 >128               
CE 200 >200                 
ACK 104 
CH 64 >128 64 >128               
CE 200 >200 200 >200               
ACK 112 
CH 64 >128 128 >128               
BE 32 >128 128 >128       128 >128 200 >200     
CE 32 >128 64 >128               ACK 116 
CH 64 >128 64 >128       200 >200       
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 Table 17 (cont.) MICs, MBCs or MFCs (µg/ml) of selected active crude extracts from actinomycetes against human pathogenic   
microorganisms 
          Test  organisms 
 
Actinomycetes 
Bacteria Yeasts Filamentous fungus 
SA MRSA PA CA28 CA53 CN12 CN13 MG PM 
Code Extract 
MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
BE           200 >200       
CE                   ACK 117 
CH                   
BE 200 >200 200 >200               
CE 64 >128 64 >128       200 >200 200 >200     ACK 119  
CH                   
Vancomycin 1 2 1 2               
Gentamicin     1 2             
Miconazole               0.5 2   
Amphotericin B       0.0625 2 0.0625 2 0.125 2 0.25 1   2 4 
                                                                                                                                                                                                                                             
SA = Staphylococcus aureus ATCC25923 CA53 = Candida albicans NCPF3153 BE = Broth EtOAc MFC = Minimal Fungicidal Concentration 
MRSA = methicillin-resistant S. aureus SK1 CN12 = Cryptococcus  neoformans ATCC90112 CE = Cell EtOAc    Strong activity : MIC ≤ 8 µg/ml 
 EC = Escherichia coli ATCC25922 CN13 = Cryptococcus  neoformans ATCC90113 CH = Cell Hexan Moderate activity : MIC 16-64 µg/ml 
 PA = Pseudomonas  aeruginosa ATCC27853 MG = Microsporum gypseum SH-MU 4 MIC = Minimal Inhibitory Concentration Weak activity : MIC 128-200 µg/ml 
CA28 = Candida albicans ATCC90028 PM = Penicillium marneffei MBC = Minimal Bactericidal Concentration  
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 3.5 Optimization of culturing conditions of actinomycetes for the production of 
antimicrobial metabolite 
 
 
3.5.1 Effect of agitation 
 
In this study the secondary metabolite productions of selected 
actinomycetes ACK 20 and ACK21 were cultured under shaking (200 rpm) and static 
conditions in ISP-2 medium pH7 at 30oC. The culture broths were incubated for 5 
weeks to investigate the inhibition activity against S. aureus and MRSA and to measure 
cell dry weight. Under the shaken condition as shown in Figure 25A and D, the growth 
of both actinomycetes increased at the first week of cultivation and the maximum 
growth was obtained at the second week, then gradually decreased, whereas the 
maximum growth under the static condition was found after 3 weeks of cultivation. 
Antibacterial activity was measured in terms of diameter of inhibition zone (mm) by 
agar well assay. It was found that the antibacterial activity was detected starting from 
the first and second week of cultivation of ACK20 and ACK21 under static condition, 
respectively and reaching its maximum activity in the fourth week of incubation against 
both S. aureus and MRSA. Culture filtrates of both isolates under static condition 
showed better antibacterial activity than those from the shaking condition (Figure 25B-
F). 
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Figure 25 Effect of culture conditions on growth and production of antibacterial 
metabolites by actinomycetes ACK20 (A-C) and ACK21 (D-F) in ISP-2 
medium pH7 at 30°C. Symbols:, static condition; , shaking condition 
(200 rpm). 
B 
Incubation time (weeks) Incubation time (weeks) 
F 
A 
Incubation time (weeks) Incubation time (weeks) 
C 
B 
D 
E 
Incubation time (weeks) 
Incubation time (weeks) Incubation time (weeks) F 
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 3.5.2 Effect of temperature  
 
The temperature for growth and antibacterial production of 
actinomycetes in this study was carried out at 25, 30 and 35oC in ISP-2 medium pH 7 
under static condition for 5 weeks. The growth of both actinomycetes cultivated at 25 
and 35oC as shown in Figure 26A and D increased at the first week of cultivation and 
the maximum growth was obtained at the third week, then gradually decreased, whereas 
the maximum growth under 30°C was found at the fifth week for ACK20. It was found 
that the antibacterial activities were detected starting from the first week of cultivation 
of ACK20 and ACK21, except the activity of ACK21 at 35°C was detected starting 
from the third and fourth weeks against S. aureus and MRSA, respectively. The 
maximum activities of ACK20 and ACK21 against S. aureus and MRSA were found in 
the fourth week at 25 and 30°C of incubations, respectively (Figure 26).     
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Figure 26 Effect of incubation temperature on growth and production of antibacterial 
metabolites by actinomycetes ACK20 (A-C) and ACK21 (D-F) in ISP-2 
medium pH7 under static condition. Symbols:, 25oC; , 30oC; , 35oC. 
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77 
 
 
 
 
 
 
I 
I I 
I 
 3.5.3 Effect of the initial pH of ISP-2 medium  
 
The initial pH of medium is important for growth and antibacterial 
production of actinomycetes. In this study actinomycetes ACK20 and ACK21 were 
inoculated in ISP-2 medium at different initial pHs (6, 7 and 8) at 25oC for ACK 20 and 
at 30oC for ACK 21 under static condition for 5 weeks. Under pH6, 7 and 8 of medium 
as shown in Figure 27A and D, the growth of both actinomycetes increased at the first 
week of cultivation and the maximum growth was achieved at the second week, then 
gradually decreased, except under cultivation at pH7 the growth of ACK20 increased at 
the first and second weeks of cultivation, then gradually decreased and the maximum 
growth was achieved at the fifth week. The best activity of ACK20 was observed in the 
medium with initial pH6 and 7 against both S. aureus ATCC 25923 and MRSA (Figure 
27B and C) whereas the best activity of ACK21 was obtained from the medium with 
initial pH 7 (Figure 27E and F).  
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 Figure 27 Effect of different initial pH of ISP-2 medium on growth and production of 
antibacterial metabolites by actinomycetes ACK20 (A-C) and ACK21 (D-
F). Symbols: , pH 6; , pH 7; , pH 8. 
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 3.6  Identification of actinomycetes 
 The top 2 actinomycetes, ACK20 and ACK21 were identified by 
morphological characteristics and molecular technique (16S rDNA).  
 
3.6.1 Morphological characteristics 
 
 The two best active actinomycetes that grew on YME agar were slow 
growing, aerobic, glabrous or chalky and with gray aerial mycelia (Figure 28A and C) 
and possessed an earthy odour. The microscopic examination of ACK21 under 
scanning electron microscope showed that the spore chains are in spiral form (Figure 
28D) which is the characteristic of the genus Streptomyces. The scanning electron 
micrograph of ACK20 revealed that this strain produced curved spore (Figure 28B). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 Morphological characteristics of ACK 20 (A and B) and ACK 21 (C and D)  
     A and C, colonial morphology on YME agar at 30°C for 6 weeks 
     B and D, Scanning electron micrographs showing curved spore and spiral 
type of spore chains, respectively 
A B 
D C 
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 3.6.2 Molecular technique (16S DNA) 
 
  The 16S DNA aligment of actinomycete ACK20 consisted of 17 taxa in 
Amycolatopsis, with Amycolatopsis alba as an outgroup. The dataset comprised 900 
characters, 875 of which were constant charecters, 9 were uninformative characters 
and 16 were informative characters. Maximum parsimony analysis yieled 1 MPT. CI 
and RI of 100 steps, 1.0000 and 1.0000 respectively. The tree from NJ analysis had an 
identical topology to the tree from the MP analysis. Actinomycetes ACK20 was 
placed in subclade A and was closely related to Amycolatopsis echigonensis 
(AB546313, NR041404 and AB248535) with short branch length and supported with 
60% and 62% bootstrap values from the MP (Figure 29)  and NJ analyses respectively. 
The nucleotide identity were 99.6, 99.3 and 99.3 %, respectively which indicated that 
ACK20 had two base difference with AB546313. ACK 20 was then identified as 
Amycolatopsis echigonensis. 
 The 16S DNA aligment of Actinomycetes ACK21 consisted of 30 taxa 
in Streptomyces, with Streptomyces aureofaciens as an outgroup. The dataset 
comprised 1124 characters, 1034 of which were constant charecters, 58 were 
uninformative characters and 32 were informative characters. Maximum parsimony 
analysis yieled 1 MPT. CI and RI of 10 steps, 0.7544 and 0.9327 respectively. The tree 
from NJ analysis had an identical topology to the tree from the MP analysis. 
Actinomycete ACK21 was placed in a species complex subclade A comprising 
Streptomyces indonesiensis (HQ244467, FJ406119), Streptomyces rhizosphaericus 
(NR041415, FJ406121), Streptomyces asiaticus (NR041418, 
HQ244468)  Streptomyces cangkringensis  (HQ244471, FJ406120) and Streptomyces 
hygroscopicus (FJ968105, EU016370) with short branch length and supported with 
99% and 98% bootstrap values from the MP (Figure 30)  and NJ analyses respectively, 
which the nucleotide identity difference between 99.3-99.7% and have 2-7 base 
difference, Therefore ACK21 was identified as Streptomyces sp.   
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Figure 29 Phylogram obtained from 16S rDNA sequence analysis of actinomycetes    
ACK20 and related Amycolatopsis echigonensis from Maximum parsimony 
analysis. Scale bar represents 0.1 base pair changes. 
Subclade A 
95/96 
60/62 
62/69 
96/97 62/64 
63/72 
87/89 
Total characters = 9000 
        Tree length = 25 
                      CI = 1.0000 
                      RI = 1.0000 
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Figure 30 Phylogram obtained from 16S rDNA sequence analysis of actinomycetes   
ACK21 and related Streptomyces sp. from Maximum parsimony analysis. 
Scale bar represents 1 base pair changes. 
Subclade A 
Total characters = 1124 
        Tree length = 115 
                      CI = 0.7544 
                      RI = 0.9327 
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CHAPTER 4 
 
DISCUSSION 
 
 
 
 
 
4.1. Antimicrobial activity 
 
It has been known for a long time that actinomycetes are a good source 
of antibiotics. The majority of antibiotics commonly used to treat infectious diseases 
are from actinomycetes. It has been extensively studied in the past. However, the 
searches for antibiotic producing actinomycetes are continuing because of a high 
demand for new types of antibiotics against drug resistant pathogens. Scientists are 
trying to screen actinomycetes that can produce antimicrobial substances from 
different sources continuously (Pandey et al., 2004; Oskay et al., 2004; Nedialkova 
and Naidenova, 2004-2005; Anansiriwattana et al., 2006; Singh et al., 2006; Parungao 
et al., 2007; Arasu et al., 2009; Dharmaraj and Sumantha, 2009; Ningthoujam et al., 
2009; Arifuzzaman et al., 2010; Dehnad et al., 2010; Hozzein et al., 2011). In this 
study, 100 selected actinomycetes isolated from soils in southern Thailand were 
screened for their ability to inhibit human pathogens. From the initial screening, 80% 
of actinomycetes showed inhibitory activity against at least one tested microorganism, 
from these 8% had antibacterial activity, 32% had antifungal activity and 40% had 
both antibacterial and antifungal activities. The percentage of active isolates obtained 
from this study is markedly high when compared with the reports of Parungao et al. 
(2007) in the Philippines (26%), Oskay et al. (2004) in Turkey (34%), Ningthoujam et 
al. (2009) and Singh et al. (2006) in India (37% and 57%, respectively). In Thailand, 
Anansiriwattana et al. (2006) isolated actinomycetes from soil and sand samples in 
Koh Samed, Rayong province, Thailand and reported that 69% of their isolates were 
active against S. aureus ATCC 25923, B. subtilis ATCC 6633 and C. albicans ATCC 
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10231. Our result is consistent with the study of de Oliveira et al. (2010) that 88.6% of 
endophytic actinobacteria tested showed antimicrobial activity against at least one 
phytopathogen. Duangsook (2010) also found that 85% of her actinomycete isolates 
have antifungal activity against fungi contaminated on pararubber sheet. The most 
active actinomycetes from this study showed antifungal activity against human 
pathogenic fungi: C. neoformans (49%), P. marneffei (41%), C. albicans (30%) and 
M. gypseum (21%), respectively. It is possible that 60% of the actinomycete strains in 
this study were known to have antifungal activity against plant fungal pathogens 
(Boukaew et al., 2010). Isolate ACK60 was most active against C. neoformans with 
the largest inhibition zone of 34.37 mm and ACK26 against C. albicans (32.45 mm) 
compared with the results from other studies. Cho et al. (2001) found that 3-hydroxy-
 -butyrolactones (50  g/disk) from Streptomyces sp. can inhibit the growth of             
C. albicans  with inhibition zone of 19.0 mm. Chatujinda et al. (2007) indicated that 
actinomycetes strain CB5-3 isolated from soil showed antifungal activity against C. 
albicans ATCC 10231 with an inhibition zone of 21.3 mm in the primary screening 
test. In addition, 11 and 30 isolates showed high inhibitory activity >80% hyphal 
growth inhibition and 9 isolates strongly inhibited both P. marneffei and M. gypseum. 
Candidiasis and cryptococcosis have emerged as major problems worldwide in cancer 
patients, transplant recipients, and other immunocompromised individuals, including 
those with AIDS (Pitisuttithum et al., 2001; Umeh and Umeakanne, 2010). 
Penicilliosis marneffei is an opportunistic fungal infection in AIDS patients with a 
high incidence in Southeast Asia, in particular in the northern part of Thailand 
(Vanittanakom et al., 2006; Hai et al., 2010). Despite advances in antifungal therapy 
in the last decade and the increasing numbers of options available for treating fungal 
infections, a high prevalence of antifungal resistance and failures of clinical treatments 
have been reported (Bueid et al., 2010; Pfaller et al., 2010, 2011). The results from 
this study showed that soil actinomycetes are a good source of antifungal compounds 
against those pathogens.  
For antibacterial activity, 40% of our soil actinomycetes inhibited both 
strains of S. aureus and only 9% and 15% inhibited E. coli and P. aeruginosa, 
respectively. In general, Gram-negative bacteria are more resistant to chemical agents 
than the Gram-positive bacteria due to their outer membrane structures that act as a 
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permeability barrier (Denyer et al., 2004; Bansal et al., 2010). ACK18 showed the 
best inhibitory activity against S. aureus with an inhibition zone of 30.95 mm and 
ACK84 against MRSA SK1 (inhibition zone 35.17 mm) whereas ACK108 had the 
best activity against E. coli (inhibition zone 32.87 mm) and ACK117 against             
P. aeruginosa (inhibition zone 33.62 mm). Schumacher et al. (2003) reported that 
bonactin from Streptomyces sp. strain BD21-2 can inhibit the growth of B. 
megaterium, M. luteus, Klebsiella pneumoniae, S. aureus, Alcaligenes faecalis, E. coli 
and Saccharomyces cerevisiae with inhibition zones in the range of only 7-10 mm. 
Chatujinda et al. (2007) reported that actinomycetes strain CB5-3 had antibacterial 
activity against S. aureus and E. coli with inhibition zones of 24.2 and 15.7 mm, 
respectively. In addition, many investigators also found that metabolites from 
Streptomyces spp. have antibacterial activities against various bacteria including        
S. aureus, MRSA, VRSA, B. subtilis, S. epidermidis, Enterococcus faecalis, 
Micrococcus luteus, E. coli, P. aeruginosa, and Klebsiella sp. (Arasu et al., 2008; 
Selvameenal et al., 2009; Yadav et al., 2009; Duraipandiyan et al., 2010; Aouiche et 
al., 2012; Dasari et al., 2012).  
The top 46 actinomycetes that can inhibit each group of the tested 
bacteria and yeasts from cross streak technique with inhibition zones over 25 mm and 
hyphal growth inhibition over 80% were selected for chemical extraction. Three types 
of crude extracts were obtained; the ethyl acetate extracts from the culture broth (BE), 
the ethyl acetate extracts from the cells (CE), and the hexane extracts from the cells 
(CH). Among these, CH extracts gave positive results more than the CE and BE 
extracts. This indicated that the active constituents are cell-bound and nonpolar. 
Holloway (2006) reported that moderate degree of polarity is a characteristic of most 
antibiotics. 
Of the 138 crude extracts from 46 actinomycetes isolates, 59.42% and 
50.72% of extracts were active against S. aureus and MRSA while only 28.26% 
showed antifungal activity. This result is in contrast to the primary screening. The 
cross streak technique can detect the water soluble substances that are diffused 
through the agar medium whereas the crude extracts are less polar. Different 
compounds can inhibit different microorganisms. Crude CH extract from ACK21 
(ACK21CH) exhibited the strongest antibacterial activity against S. aureus and MRSA 
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with MIC/MBC 0.5/4 and 0.5/8 µg/ml, respectively followed by ACK20CE against S. 
aureus and MRSA with MIC/MBC 2/8 µg/ml, 0.5/2 µg/ml, respectively. Thess results 
are comparable to the standard drug vancomycin (MIC/MBC 1/2 µg/ml). None of the 
extracts inhibited E. coli (MIC and MBC>200 µg/ml) and only one extract 
(ACK20CH) was active against P. aeruginosa with MIC/MBC values 200/>200 
µg/ml. Compared with the results of Duraipandiyan et al. (2010), actinomycetes 
ERIH-44 showed both antibacterial and antifungal activity with MICs against B. 
subtilis (<15.62 µg/ml), S. aureus (<15.62 µg/ml), E. coli (125 µg/ml) and P. 
aeruginosa (500 µg/ml), Botrytis cinerea (500 µg/ml) and Trichophyton 
mentagrophytes (1000 µg/ml). Aouiche et al. (2012) reported that isolate PAL111 
showed a strong activity against C. albicans, filamentous fungi, and Gram-positive 
and Gram-negative bacteria with MICs between 2 and 20 µg/ml for yeast, 10 and 50 
µg/ml for filamentous fungi, 2 and 10 µg/ml for Gram-positive bacteria and 20 and 75 
µg/ml for Gram-negative bacteria. In addition, the effects of ACK20CE and 
ACK21CH at 4 times MIC were also observed by SEM along with the vancomycin. 
Both extracts had an effect on the morphological structure of the cells which was 
indicated by the presence of pores and shrinkage in the cell wall. Some cells had 
undergone cell lysis. This may be due to the imperfect synthesis of the cell wall. The 
cells in contact with actinomycete extracts had more damaged cells (Figures 23C, 
23D, 24C, 24D) than those treated with vancomycin (at 4MIC) (Figures 23B and 
24B). Vancomycin inhibits the bacterial cell wall synthesis by strongly binding to the 
end of the D-Ala-D-Ala, therefore it inhibits peptidoglycan synthesis and also inhibits 
the cross linkage. The cell becomes vulnerable and easily lysed causing the cell wall 
shrunk. Besides that the cell membrane also becomes damaged leading to cell death 
(Anam et al., 2010). The SEM result indicated that ACK20CE and ACK21CH 
interfere the cell wall synthesis. Active compounds from these two isolates are under 
investigation. 
For antifungal activity, crude CH extract from ACK21 (ACK21CH) 
exhibited the strongest antifungal activity against C. albicans NCPF3153 with 
MIC/MFC 4/128 µg/ml which is better than the results from other investigations. 
Arasu et al. (2008) reported that extract from actinomycetes isolate ERI-26 showed 
the MIC of 500 µg/ml against C. albicans  while Gandhimathi et al. (2008) found that 
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extract from Streptomyces sp. strain CPI 13 inhibited C.  tropicalis with MIC and 
MFC values of 10 and 12.5 µg/ml, respectively. The extracts had less activity against 
C. neoformans, M. gypseum and P. marneffei. However, this is the first study of 
actinomycetes against P. marneffei. Although only 5% of the extracts were active 
against P. marneffei with MIC of 200 µg/ml, but it is worth noting that many 
actinomycetes could completely inhibit the hyphal growth of this fungus. The active 
actinomycetes may produce polar antifungal compounds into the agar medium. 
 
4.2 Optimization of the antimicrobial production by actinomycetes ACK20 and 
ACK21 
As isolates ACK20 and ACK21 showed the best antimicrobial activity, 
they were then selected for the optimization study. Effects of agitation, pH of initial 
medium and incubation temperature on the production of antimicrobial compounds by 
ACK20 and ACK21 were investigated.  The cell mass obtained from each condition 
was measured and antibacterial activity of culture broth against S. aureus ATCC 
25923 and MRSA were detected by agar well diffusion.  
The production of antibacterial agents by ACK20 and ACK21 was 
carried out in ISP-2 broth. ISP media were developed by Difco Laboratories for the 
International Streptomyces Project (ISP). ISP-2 is also referred to as Yeast Extract-
Malt Extract agar and contains 0.4% yeast extract, 1% malt extract and 0.4% dextrose. 
Yeast extract and malt extract provide nitrogen, amino acids and vitamins, and 
dextrose is the main carbon source (Duangsook, 2010). ISP-2 is the traditional 
medium used to determine the cultural characteristics of actinomycetes. However, it 
has also been used by many investigators for production of antimicrobial agents by 
various actinomycetes (Augustine et al., 2005; Boudjella et al., 2006; Thakur et al., 
2009; Duangsook, 2010; Nookao, 2011).  
Cultivation conditions play an important role in the antibiotic 
production by actinomycetes. In this study, the production of antibacterial compounds 
by ACK20 and ACK21 was carried out in static and shaking cultures. Both isolates 
grew well under shaking condition but the antibacterial activity obtained from static 
cultures was higher than those from the shaking cultures. Antibiotics are secondary 
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metabolites which microorganisms produce in the stationary phase. A high degree of 
oxygen transfer during the exponential growth phase may ultimately help to improve 
antibiotic production. Different strains require different cultivation conditions. Many 
investigators have found that their actinomycetes produce high antibiotic yields in 
shake flask condition (Boudjella et al., 2006; Singh et al., 2009; Thakur et al., 2009). 
Thakur et al. (2009) reported that the optimum production of the antimicrobial agent 
by Streptomyces sp. 201 in laboratory-scale fermentation could be achieved in culture 
medium supplemented with mannitol at a concentration of 1.5 g/l as carbon and 
asparagine concentration 0.9 g/l as nitrogen sources, temperature at 30oC, initial pH  
of the medium 7.5, inoculum size equal to 2x109 spore/ml and incubation period of 60 
days under shaking condition. In the contrary, other studies by Hassan et al. (2001), 
El-sersy and Abou-Elela (2006), Al-Zahrani (2007) and Duangsook (2010) have 
shown that the static condition is good for their isolates. Therefore, each isolate must 
be checked for its optimum culture condition.  
The biosynthesis of secondary metabolites by microorganisms is 
regulated by the growth temperature. In this study, the maximum activity of ACK20 
and ACK21 against S. aureus and MRSA was found in the fourth week at 25 and 
30°C of incubation, respectively. Boudjella et al. (2006) studied the antimicrobial 
production of Streptosporangium sp. Sg 10 cultured in ISP 2 broth, pH 7.2 in a rotary 
shaker at 250 rpm, at 30oC for 17 days and tested against M. luteus and Mucor 
ramannianus by agar diffusion method. The antimicrobial activity was detected on 
day 4 until day 11 of incubation and the antibacterial was stronger than the antifungal 
activity. In 2010, de Oliveira et al. reported that the metabolite produced by 
Streptomyces sp. R18(6) grown in SC broth at 30oC and pH 7.0 showed the best 
inhibition zone observed with the diffusion-well method. Nookao (2011) indicated 
that actinomycetes strain KM 1.1-7.9 grown in GMP liquid medium on a rotary shaker 
(180 rpm) at 30oC for nine days produced antibacterial metabolites against Ralstonia 
solanacearum.  
Another important factor affecting antibiotic production is the initial 
pH of medium. The activity of several major enzymes that catalyze metabolic 
reactions of cell growth and antibiotic formation are affected by pH (Guimaraes et al., 
2004; Liang et al., 2008). In general, the growth pH range of actinomycetes is 6.5-8.0 
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(Locci, 1989) and the optimum pH is 7.0 (Jensen, 1991). ACK20 and ACK21 grew 
well in all pHs studied and the cell mass increased at the first week of cultivation and 
the maximum growth was achieved at the second week, then gradually decreased, 
except for ACK20 under cultivation at pH7. The best activity of ACK20 and ACK21 
was observed in the medium with initial pH6-7 and pH 7, respectively. Kontro et al. 
(2005) studied the pH effects on growth and sporulation of ten Streptomyces spp. The 
growth pH ranges and pH ranges for the optimal growth of those Streptomyces spp. 
were strongly dependent on the nutrient composition of the media but the ability to 
sporulate was independent of the pH and medium composition.  
The optimum culture conditions for the production of antimicrobial 
metabolites from many studies, have varied. In 2005, Augustine et al. reported that the 
optimum conditions for antifungal metabolite production of Streptomyces rochei AK 
39 were starch casein medium pH 7 containing glycerol 1.2%, agitation at 200 rpm, 
temperature at 37oC. Oskay (2009) reported that the optimum conditions for 
antimicrobial production by Streptomyces sp. KEH 23 were an initial pH of 7.5, a 
temperature of 30oC under shaking condition. The optimum conditions for 
Streptomyces tanashiensis strain A2D were 28oC, at a pH of 8 under shaking 
condition and this strain grew upto pH 9, and indicated that this strain was part of the 
alkaliphilic actinomycetes group (Singh et al., 2009). In addition, Duangsook (2010) 
found that the optimum conditions for the production of antifungal metabolites by 
Streptomyces spp. AC41 and AC51 against fungi contaminated on rubber sheet were 
under the static condition, a pH of 7 at 30oC for 6 weeks. In this study, the optimum 
conditions for the production of antimicrobial metabolites by isolates ACK20 were pH 
6-7 at 25oC under static condition for 4 weeks and by ACK21 were pH 7 at 30oC for 4 
weeks. Both isolates are mesophilic and neutrophilic. 
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4.3 Identification of actinomycetes  
 
In this study, the two best antimicrobial producing isolates ACK20 and 
ACK 21 were identified based on morphological and molecular characteristics as 
Amycolatopsis echigonensis and Streptomyces sp., respectively. A. echigonensis was 
first isolated from a filtration substrate made from Japanese volcanic soil and 
described as a new species based on morphological, physiological and genotypic 
characteristics by Ding et al. in 2007. The genus is known to contain numerous 
antibiotic producing strains, with the glycopeptide (e.g. vancomycin) and ansamycin 
(e.g. rifamycin) producers being the most important to medicine. PCR screening for 
antibiotic biosynthetic potential revealed the presence of antibiotic biosynthetic genes 
in all the Amycolatopsis type strains (Everest and Meyers, 2011). Recently, Igarashi  
et al. (2008) reported that Amycolatopsis ML1-hF4 produced pargamicin A, a novel 
cyclic peptide antibiotic with a potent antibacterial activity against S. aureus strains 
including MRSA and Enterococcus faecalis/faecium strains including vancomycin-
resistant enterococci (VRE). Extracts from A. echigonensis ACK20 showed both 
antibacterial and antifungal activities but the antibacterial activity is much stronger 
than the antifungal one. To our knowledge this is the first report on antimicrobial 
metabolites produced by A. echigonensis. The chemical contituents produced by this 
strain is under investigation. 
Streptomyces sp. ACK21 was grouped together with S. cangkringensis, 
S. asiaticus, S. rhizosphaericus, S. indonesiensis, S. hygroscopicus and Streptomyces 
sp. 02-32. The first four species are members of Streptomyces violaceusniger clade 
which is known to be antagonistic to various plant pathogenic fungi (Sembiring et al., 
2000) and a source of antibacterial and antifungal metabolites (Goodfellow et al., 
2007). S. cangkringensis, S. asiaticus and S. indonesiensis were described as new 
species by Sembiring et al. in 2000. They shared 16S rRNA gene similarities within 
the range of 99.2 – 99.7 values that correspond to between 4 and 6 nucleotide 
differences (Goodfellow et al., 2007). S. asiaticus and S. indonesiensis were first 
isolated from rhizosphere soils whereas S. cangkringensis was from the non-
rhizosphere soil adjacent to a stand of the tropical legume, Paraserianthes falcataria 
in Indonesia. They produce spiral spore chains and the spore surface is rugose. Our 
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Streptomyces sp. ACK21 produces spiral spore chain too. Like A. echigonensis there 
is no detailed reports on the production of antibiotics from these three species. 
Streptomyces hygroscopicus and related species are the most well known candidate 
producers of antibiotics and many other industrially and agronomically important 
secondary metabolites in the genus Streptomyces. Currently more than 650 kinds of 
bioactive substances have been produced by S. hygroscopicus and related species 
(Rong and Huang, 2012). The examples of antibiotics produced by S. hygroscopicus 
are such as geldamycin (antitumor), hygromycin B (anthelmintic), nigericin (against 
Gram-positive bacteria) and validamycin (fungicide). All three extracts from our 
isolate Streptomyces sp. ACK21 exhibited the strongest antibacterial activity against 
S. aureus strains including MRSA with MICs lower than vancomycin. The chemical 
contituents produced by ACK21 is under investigation.  
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CHAPTER 5 
 
CONCLUSIONS 
 
 
 
 
5.1 Conclusions 
 
In this study, total of 100 actinomycetes isolated from soils from four 
provinces in southern Thailand were screened for their ability to produce antimicrobial 
substances by cross streak and hyphal growth inhibition tests against ten human 
pathogens. Eighty percents of the isolates showed antimicrobial activity against at 
least one test microorganism. Among them, 8% inhibited only bacteria, 32% inhibited 
only yeasts and/or fungi and 40% had both antibacterial and antifungal activities. For 
antibacterial activity, 40% of soil actinomycetes inhibited both strains of S. aureus and 
only 9% and 15% inhibited E. coli and P. aeruginosa, respectively. For antifungal 
activity, 21, 30, 41, and 49% inhibited M. gypseum, C. albicans, P. marneffei and       
C. neoformans, respectively. 
Forty-six active isolates that showed inhibition zone over 25 mm and 
hyphal growth inhibition over 80% were selected and cultured in Yeast Malt Extract 
broth for extraction of bioactive compound. Three types of crude extracts, BE, CH and 
CE were obtained. CH provided the highest active extracts (34/46, 73.91%) followed 
by CE (31/46, 67.39%), and BE (25/46, 54.34%), respectively. Crude extracts were 
then tested for their MICs,
 
MBCs and MFCs by broth microdilution methods 
according to Clinical and Laboratory Standards Institute (CLSI). Ninety extracts out of 
138 total extracts from 46 actinomycete isolates were inhibitory. They can inhibit both 
strains of S. aureus with MIC values of 0.5-200 µg/ml and MBC values of 2->200 
µg/ml, respectively. Crude CH extracts from ACK21 (ACK21CH) exhibited the 
strongest antibacterial activity against S. aureus and MRSA with MIC/MBC 0.5/4 and 
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0.5/8 µg/ml, respectively followed by ACK20CE against S. aureus and MRSA with 
MIC/MBC 2/8 µg/ml, 0.5/2 µg/ml, respectively. In addition, scanning electron 
microscopic study showed that extracts from ACK21CH and ACK20CE strongly 
destroyed S. aureus cells causing cytoplasm leakage and cell death.  
Three factors including agitation, temperature and initial pH of the 
medium on the production of antimicrobial metabolites by the isolates ACK21 and 
ACK20 were investigated. The optimum condition for ACK21 was observed at the 
static condition, pH7 and temperature 30oC and ACK20 was observed at the static 
condition, pH6 and 7 and temperature 25oC for 4 weeks for the production of 
antibacterial metabolites against both S. aureus ATCC25923 and MRSA.  
Based on morphological characteristics and 16S DNA analysis, ACK21 
was identified as Streptomyces sp. and ACK20 as Amycolatopsis echigonensis. 
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5.2 Suggestion for future work  
 
1) Purification and structural identification of the bioactive compounds 
from the most active Streptomyces sp. ACK21 and Amycolatopsis echigonensis 
ACK20 
2) Study on mechanisms of action of bioactive compounds from these 
two best active isolates 
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APPENDIX 
 
 
Actinomycete Isolation Agar (AIA)   1 litre 
  Sodium caseinate   2.0     g 
  Asparagine               0.1     g 
  Sodium propionate   4.0     g 
  Dipotassium phosphate  0.5     g 
  Magnesium sulfate   0.1     g 
  Ferrous sulfate              0.001 g 
  Agar     15.0   g 
 
 
Nutrient Agar (NA)     1 litre 
  Beef extract    3.0     g 
  Peptone    5.0     g 
  Agar     15.0   g 
  
 
Yeast extract-malt extract broth (ISP-2)     1 litre 
  Malt extract    10.0 g 
  Yeast extract      4.0 g 
  Glucose      4.0 g 
  pH       7 
 
 
1.8% resazurin 
  Add 1.8 g of resazurin dye to 100 ml of distilled water and mix 
thoroughly. Filter resarurin dye solution with membrane 0.45 µm and store in 
eppendorf wrapping with foil at 4 oC. Dilute 1.8% resazurin with sterile distilled water 
to 1:10 and mix thoroughly before using for antimicrobial test. 
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Neighbour-joining: Neighbor-joining is based on the minimum-
evolution criterion for phylogenetic trees, i.e. the topology that gives the least total 
branch length is preferred at each step of the algorithm. However, neighbor-joining 
may not find the true tree topology with least total branch length because it is a greedy 
algorithm that constructs the tree in a step-wise fashion. Even though it is sub-optimal 
in this sense, it has been extensively tested and usually finds a tree that is quite close 
to the optimal tree. Nevertheless, it has been largely superseded in phylogenetics by 
methods that do not rely on distance measures and offer superior accuracy under most 
conditions (Duangsook, 2010) 
 
  Maximum parsimony: Maximum parsimony is a character-based 
method that infers a phylogenetic tree by minimizing the total number of evolutionary 
steps required to explain a given set of data, or in other words by minimizing the total 
tree length. The trees requiring the fewest character state changes are considered 
optimal. Individual characters are termed “informative” in maximum parsimony 
analysis when they require different numbers of changes on different trees. To be 
informative, an unpolarized character must have at least two character states and each 
state must be present in at least two taxa. Character state changes required for the tree 
is the length of the tree. As the number of taxa increases, the number of possible trees 
increases even faster, finding the most parsimonious trees (MPTs) for a given data set 
can be a computationally intensive task to choose the tree that result in fewest 
character state changes. (Duangsook, 2010) 
 
  Bootstrapping (Simpson, 2006): Bootstrapping is a resampling tree 
evaluation method that works with distance, parsimony, likelihood and just about any 
other tree derivation method. The result of bootstrap analysis is typically a number 
associated with a particular branch in the phylogenetic tree that gives the proportion of 
bootstrap replicates that supports the monophyly of the clade. Bootstrap values greater 
than 70% correspond to a probability of greater than 95% that the true phylogeny has 
been found and greater than 50% will be an overestimate of accuracy. A high 
bootstrap value can make the right phylogeny. 
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  Consistency index (CI) (Simpson, 2006): One measure of the relative 
amount of homoplasy in the cladogram is the consistency index. The consistency 
index is equal to the ratio of minimum changes of character state or minimum possible 
tree length that must occur and the actual number of changes or tree length that do 
occur. A consistency index close to 1 indicates little to no homoplasy; a CI close to 0 
is indicative of considerable homoplasy. 
              
   
 
 
  
Retention index (RI) (Simpson, 2006): The retention index is calculated as the ratio 
(g-s)/(g-m), where g is the maximum possible tree length that could occur on any 
conceivable tree, s and m are tree length and minimum possible tree length, 
respectively. Thus, the RI is influenced by the number of taxon in the study. A 
consistency index close to 1 indicates little to no homoplasy; a RI close to 0 is 
indicative of considerable homoplasy. 
 
 
                                              
   
                        
 
 
 
 
 
 
 
 
 
                             Maximum possible tree length - tree length  
  RI =  
              Maximum possible tree length - minimum possible tree length 
             Minimum possible tree length  
CI = 
                             Tree length 
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